Crohn's Disease , ITF2357 , Italfarmaco ,20-Oct-07, Phase 1 , Terminated\,,,,  Crohn's Disease , Contrast Enhanced Ultrasound , University of Michigan ,20-Feb-15, Phase 1 , Withdrawn\,,,, Polycystic Liver Disease , Lanreotide Autogel 90 mg and 120 mg , Universitaire Ziekenhuizen Leuven ,20-Mar-11, Phase 2 , Completed\,,,, Autoimmune/Connective Tissue Diseases , Anakinra , National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) ,20-Sep-11, Phase 1 , Completed\,,,, Sickle Cell Disease , Placebo , Virginia Commonwealth University , June 2007 , Phase 1 , Withdrawn\,,,, Chronic Obstructive Pulmonary Disease (COPD) , Disease Management , Air Liquide Sant'e9 International ,20-Sep-10, Phase 4 , Completed\,,,, Parkinson Disease , [18F]MK-9470 , Institute for Neurodegenerative Disorders ,20-May-11, Phase 1 , Completed\,,,, Cough , Capsaicin , University of Florida ,20-Oct-14, Phase 1 , Completed\,,,, Graft Versus Host Disease , graft versus host disease prophylaxis/therapy , Fred Hutchinson Cancer Research Center , June 2012 , Phase 2 , Completed\,,,, Heart Disease , Hybrid revascularization , Silesian Centre for Heart Diseases ,20-Nov-09, Phase 2 , Completed\,,,, Crohn's Disease , Capsule Endoscopy , University of Rochester , June 2005 , Phase 1 , Withdrawn\,,,, Acute GVH Disease , Human Umbilical Cord Derived MSC , Affiliated Hospital to Academy of Military Medical Sciences ,20-Dec-12, Phase 1 , Enrolling by invitation\,,,, Crohn's Disease , STA-5326 , Synta Pharmaceuticals Corp. ,20-Feb-04, Phase 1 , Completed\,,,, Parkinson Disease , GM1 ganglioside , Thomas Jefferson University ,19-Nov-99, Phase 2 , Completed\,,,, Heart Failure , Home-based disease management , Japanese Heart Failure Outpatient Disease Management Evaluation Investigators ,20-Jan-07, Phase 3 , Completed\,,,, Parkinson's Disease , CJH1 (CLR4001) , Alexandra Marine and General Hospital ,20-Sep-12, Phase 1 , Unknown status\,,,, Lyme Disease , Education about disease prevention , Brigham and Women's Hospital ,19-Apr-97, Phase 3 , Completed\,,,, Parkinson's Disease , 18F-DTBZ , Chang Gung Memorial Hospital ,20-May-10, Phase 2 , Completed\,,,, Crohn Disease , Wellbutrin (bupropion) , Altschuler Eric M.D., May 2005 , Phase 2 , Completed\,,,, Crohn's Disease , Crohn's Disease , Ferring Pharmaceuticals ,20-Oct-05, Phase 4 , Completed\,,,, Parkinson Disease , [123I] IBVM and SPECT imaging, Institute for Neurodegenerative Disorders , November 2006 , Phase 2 , Active, not recruiting\,,, Crohn Disease , rhIGF (Increlex) , Nationwide Children's Hospital ,20-Oct-08, Phase 2 , Terminated\,,,, Chronic Beryllium Disease , Mesalamine , National Jewish Health ,20-Mar-10, Phase 1 , Completed\,,,, Crohn's Disease , Adalimumab , Abbott ,20-Apr-07, Phase 3 , Completed\,,,, Idiopathic Parkinson's Disease , Transdermal nicotine , Assistance Publique - H\'f4pitaux de Paris ,20-Feb-09, Phase 2 , Completed\,,,, Parkinson Disease , CEP-1347 10mg , Cephalon ,20-Mar-02, Phase 2 , Terminated\,,,, Sensorineural Hearing Loss , Anakinra , Andrea Vambutas , June 2011 , Phase 1 , Completed\,,,, Parkinson's Disease , Transcranial Magnetic Stimulation (TMS) , University of Florida ,20-Aug-13, Phase 0 , Completed\,,,, Crohn Disease , Infliximab with azathioprine (IIFX + AZA) , Children's Memorial Health Institute - Poland, November 2008 , Phase 3 , Unknown status\,,,, Crohn Disease , Infliximab 5 mg/kg , Centocor Inc., June 1995 , Phase 2 , Completed\,,,, Alzheimer Disease , [18F] PBR111 , Institute for Neurodegenerative Disorders ,20-Mar-10, Phase 1 , Completed\,,,, Graft Versus Host Disease , Rapamycin , Yale University ,20-Feb-08, Phase 1 , Terminated\,,,, Crohn's Disease , bowel prep regimen first boost 6 oz. and second boost 3 oz. , Given Imaging Ltd. ,20-Mar-12, Phase 1 , Completed\,,,, Bipolar Disorder , Chronic care model for Bipolar Disorder , VA Office of Research and Development ,20-May-08, Phase 3 , Completed\,,,, Alzheimer's Disease , I-123-MNI-168 , Institute for Neurodegenerative Disorders ,20-Jan-09, Phase 1 , Terminated\,,,, Crohn Disease , Sargramostim (Leukine) , Genzyme - a Sanofi Company, December 2004 , Phase 1 , Terminated\,,,, Alzheimer's Disease , lipoic acid and fish oil concentrate , Oregon Health and Science University ,20-Sep-10, Phase 1 , Unknown status\,,,, Diabetes Mellitus, With Complications , Intravenous Insulin on cardiac disease in diabetic pts -  Florida Atlantic University, September 2007 , Phase 3 , Withdrawn\,,,, Bowens Disease , Imiquimod , Brooke Army Medical Center ,20-Nov-06, Phase 2 , Enrolling by invitation\,,,, Crohn's Disease , Nitazoxanide , Romark Laboratories L.C. ,20-Aug-05, Phase 2 , Terminated\,,,, Coronary Heart Disease , Supervised exercise on a stationary bicycle -  3-5 days a week, Basque Health Service , January 2005 , Phase 3 , Completed\,,,, Diabetes , umbilical cord mesenchymal stem cells , Institute of Hematology & Blood Diseases Hospital ,20-Feb-14, Phase 1 , Enrolling by invitation\,,,, Graft-Versus-Host Disease , Cyclosporine , Hospital Universitario Dr. Jose E. Gonzalez ,20-May-14, Phase 2 , Completed\,,,, Glioblastoma , New Castle Disease Virus , Hadassah Medical Organization , July 2011 , Phase 1 , Withdrawn\,,,, Parkinson's Disease , ONO-2506PO , Ono Pharmaceutical Co. Ltd ,20-Jan-04, Phase 2 , Completed\,,,, Crohn Disease , Autologous mesenchymal stem cells , Clinica Universidad de Navarra, June 2010 , Phase 1 , Completed\,,,, Huntington's Disease , SEN0014196 , Siena Biotech S.p.A. ,20-Nov-11, Phase 1 , Completed\,,,, Alzheimer Disease , Transdermal estradiol , University of Wisconsin- Madison, September 2001 , Phase 2 , Completed\,,,, Parkinson Disease , [18F] CFPyPB , Institute for Neurodegenerative Disorders ,20-Aug-11, Phase 1 , Completed\,,,, Alzheimer's Disease , Isotretinoin , University Hospitals Cleveland Medical Center ,20-Apr-12, Phase 1 , Terminated\,,,, Crohn's Disease , Human Placenta-Derived Cells PDA001 Intravenous Infusion , Celgene Corporation ,20-Aug-10, Phase 2 , Completed\,,,, Parkinson Disease , [123I] IBVM and SPECT imaging , Institute for Neurodegenerative Disorders , July 2007 , Phase 0 , Completed\,,,, Rheumatic Valve Disease , Cardioblate\'ae Surgical Ablation System , China National Center for Cardiovascular Diseases ,20-Mar-08, Phase 3 , Unknown status\,,,, Crohn's Disease , Certolizumab pegol , UCB Pharma ,20-Jan-07, Phase 3 , Completed\,,,, Crohn's Disease , Hematopoietic stem cell transplantation , University of California - Los Angeles, February 2014 , Phase 0 , Withdrawn\,,,, Autoimmune Diseases , Evaluation of vaccines against flu , Assistance Publique - H\'f4pitaux de Paris ,20-Oct-09, Phase 4 , Completed\,,,, Crohn's Disease , Treatment Algorithm for Crohn's Disease , University of Western Ontario - Canada, January 2010 , Phase 4 , Completed\,,,, Alzheimer's Disease , CERE-110: Adeno-Associated Virus Delivery of NGF , Ceregene ,20-Sep-09, Phase 2 , Active, not recruiting\,,, Crohn's Disease , QAX576 , Novartis Pharmaceuticals , June 2011 , Phase 2 , Completed\,,,, Coronary Artery Disease , Influenza vaccination: Influvac (SolvayPharma) , Institute of Cardiology - Warsaw - Poland, October 2004 , Phase 2 , Completed\,,,, Crohn's Disease , adalimumab , AbbVie (prior sponsor -  Abbott), February 2011 , Phase 3 , Completed\,,,, Inflammatory Bowel Disease , Multi-Convergent Therapy , Cardiff and Vale University Health Board ,20-Jan-11, Phase 1 , Completed\,,,, Crohn's Disease , VSL#3 , Federico II University ,20-Sep-12, Phase 4 , Unknown status\,,,, Meniere's Disease , Betahistine 24 mg bid (Betaserc) , Solvay Pharmaceuticals ,20-Jan-03, Phase 4 , Completed\,,,, Crohn's Disease , Measurement of serum infliximab and anti-infliximab antibodies , Copenhagen University Hospital at Herlev , June 2009 , Phase 4 , Unknown status\,,,, Cardiovascular Diseases , lecture , Northwestern University ,20-Oct-10, Phase 0 , Completed\,,,, Alzheimer Disease , galantamine , Janssen Pharmaceutical K.K. ,20-Apr-01, Phase 3 , Completed\,,,, Alzheimer's Disease , Drug: NIC5-15 , Humanetics Corporation ,20-Apr-07, Phase 2 , Completed\,,,, Crohn's Disease , Given\'ae Diagnostic System including PillCamTM SB Capsules , Rabin Medical Center ,20-Jan-07, Phase 3 , Completed\,,,, Huntington's Disease , Placebo , Medivation Inc., July 2007 , Phase 2 , Completed\,,,, Inflammation , Naltrexone-HCl , Penn State University ,20-Sep-06, Phase 2 , Completed\,,,, Crohn's Disease , adult human mesenchymal stem cells , Mesoblast International S\'e0rl ,20-May-07, Phase 3 , Active, not recruiting\,,, Heart Disease, Ischemic , Gadolinium -  Northwestern University, June 2010 , Phase 2 , Completed\,,,, Parkinson's Disease , Repetitive Transcranial Magnetic Stimulation , University Hospital -  Toulouse, October 2010 , Phase 2 , Completed\,,,, IDIOPATHIC PARKINSON'S DISEASE , Rotigotine , UCB Pharma , July 2012 , Phase 3 , Completed\,,,, Parkinson's Disease , Pioglitazone , University of Rochester ,20-Mar-11, Phase 2 , Completed\,,,, Parkinson Disease , [123I] 5-IA , Institute for Neurodegenerative Disorders ,20-Nov-06, Phase 2 , Completed\,,,, Von Willebrand Disease , Biostate\'ae , CSL Behring , June 2009 , Phase 2 , Completed\,,,, Parkinson's Disease , SPM 962 , Otsuka Pharmaceutical Co. Ltd, January 2008 , Phase 2 , Completed\,,,, Parkinson Disease , Erythropoietin human recombinant (EPOrh) , International Center for Neurological Restoration - Cuba, August 2008 , Phase 1 , Completed\,,,, Crohn's Disease , certolizumab pegol , UCB Pharma ,20-Aug-10, Phase 2 , Active, not recruiting\,,, Lyme Disease , Skin Biopsy , National Institute of Allergy and Infectious Diseases (NIAID) ,20-May-10, Phase 0 , Completed\,,,, Parkinson's Disease , nicotine , Neuraltus Pharmaceuticals Inc., October 2009 , Phase 1 , Completed\,,,, Parkinson Disease , DBS Surgery , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Nov-11, Phase 1 , Withdrawn\,,,, Autoimmune Diseases , Autologous hematopoietic stem cell transplantation , Charite University - Berlin - Germany, January 1998 , Phase 1 , Unknown status\,,,, Rheumatic Heart Disease , mHealth , Sri Sathya Sai Institute of Higher Medical Sciences ,20-Aug-14, Phase 2 , Completed\,,,, Alzheimer Disease , atomoxetine hydrochloride , Eli Lilly and Company ,20-Oct-03, Phase 2 , Completed\,,,, Crohn's Disease , Rifaximin-EIR , Alfa Wassermann S.p.A. ,20-Sep-07, Phase 2 , Completed\,,,, Cardiovascular Disease , Periodontal therapy , Boston University ,20-Sep-04, Phase 2 , Unknown status\,,,, Chronic Disease , Internet Chronic Disease Self-Management Program (ICDSMP) , Stanford University ,20-Oct-08, Phase 3 , Completed\,,,, Crohn's Diseases , FMT , The Second Hospital of Nanjing Medical University ,20-Nov-12, Phase 2 , Unknown status\,,,, Crohn Disease , UC-MSCs by peripheral intravenous infusion , Fuzhou General Hospital , June 2012 , Phase 1 , Completed\,,,, Parkinson's Disease , RM-131 , Motus Therapeutics, Inc. , September 2013 , Phase 2 , Terminated\,,, Parkinson Disease , coenzyme q10 , National University Hospital, Singapore , June 2012 , Phase 2 , Completed\,,, Alzheimer's Disease , Dimebon , Medivation, Inc. , May 2008 , Phase 3 , Completed\,,, Chronic Kidney Disease , Video Telemonitoring Device with Clinical Care Modules , Minneapolis Veterans Affairs Medical Center ,20-Mar-12, Phase 3 , Completed\,,,, Alzheimer's Disease , PF-04360365 0.1 mg/kg , Pfizer ,20-Dec-08, Phase 2 , Completed\,,,, Sjogren's Disease , Rituximab (mabthera) Injection , University Hospital, Brest , March 2008 , Phase 2 , Completed\,,, Pre-hypertension , carvedilol phosphate , University of Minnesota - Clinical and Translational Science Institute ,20-Nov-07, Phase 1 , Completed\,,,, Alzheimer's Disease , PF-04360365 10 mg/kg , Pfizer ,20-Aug-09, Phase 2 , Completed\,,,, Crohn's Disease , AMG 827 350 MG , Amgen , July 2010 , Phase 2 , Terminated\,,,, Crohn's Disease , QBECO , Qu Biologics Inc. ,20-Mar-13, Phase 1 , Completed\,,,, Crohn Disease , CCX282-B , ChemoCentryx ,20-Aug-04, Phase 2 , Completed\,,,, Parkinson's Disease , Medtronic Activa PC+S Sensing Deep Brain Stimulator Generator , Nader Pouratian ,20-Sep-15, Phase 1 , Withdrawn\,,,, Parkinson Disease , Isradipine , University of Rochester ,20-Sep-14, Phase 3 , Active, not recruiting\,,, Parkinson's Disease , Rotigotine , Azienda Ospedaliera Cardinale G. Panico ,20-Dec-13, Phase 2 , Terminated\,,,, Collapsing Glomerulopathy , Kidney needle biopsy , National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,20-Nov-04, Phase 1 , Completed\,,,, Alzheimer's Disease , Nicotinamide , University of California, Irvine , January 2008 , Phase 1 , Unknown status\,,, Alzheimer's Disease , PPI-1019 (APAN) , PRAECIS Pharmaceuticals Inc. ,20-Dec-04, Phase 1 , Completed\,,,, Inflammatory Bowel Diseases , Mesalazine, Tripterygium glycosides , Zhu Weiming , January 2014 , Phase 2 , Unknown status\,,, Huntington's Disease , Dimebon , Medivation, Inc. , October 2006 , Phase 1 , Completed\,,, Hodgkin's Disease , G-CSF Plus Plerixafor , Genzyme, a Sanofi Company , November 2004 , Phase 2 , Completed\,,, Crohn's Disease , adult human mesenchymal stem cells , Mesoblast International S\'e0rl ,20-Sep-10, Phase 3 , Active, not recruiting\,,, Coronary Artery Disease , 99mTc-ECDG , Cell>Point LLC ,20-Feb-14, Phase 2 , Enrolling by invitation\,,,, Crohn's Disease , PF-00547659 SC injection , Pfizer ,20-Apr-11, Phase 2 , Completed\,,,, Chronic Granulomatous Disease , Infliximab , National Institute of Allergy and Infectious Diseases (NIAID) ,20-May-06, Phase 1 , Terminated\,,,, Parkinson's Disease , ioflupane 123I (DATSCAN\'ae) , University Hospital, Toulouse , March 2009 , Phase 2 , Completed\,,, Crohn's Disease , growth hormone , Children's Hospital Medical Center, Cincinnati , April 2005 , Phase 2 , Completed\,,, Celiac Disease , Bifidobacterium breve , University Clinical Centre, Maribor , October 2013 , Phase 1 , Completed\,,, Chronic Graft Versus Host Disease , Biological: mesenchymal stem cell , Chinese Academy of Medical Sciences ,20-Feb-12, Phase 2 , Unknown status\,,,, Behavioral Manifestations of Lesch-Nyhan Disease , sapropterin , University of California, San Diego , July 8-2009, Phase 2 , Withdrawn\,,, Parkinson's Disease , deferiprone , University Hospital, Lille , October 2009 , Phase 2 , Completed\,,, Alzheimer Disease , AADvac1 , Axon Neuroscience SE ,20-May-13, Phase 1 , Completed\,,,, Alzheimer Disease , Rofecoxib , National Institute on Aging (NIA) ,Feb 28-2000,2000, Phase 2 , Completed\,,, Fabry Disease , Replagal agalsidase alfa , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Oct-03, Phase 1 , Completed\,,,, Crohn's Disease , Certolizumab Pegol , UCB Japan Co. Ltd. ,20-Mar-06, Phase 2 , Completed\,,,, Celiac Disease , Aspergillus niger prolyl endoprotease , VU University Medical Center ,20-May-08, Phase 1 , Completed\,,,, Alzheimer\'b4s Disease , Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 400 mg/kg , Baxalta US Inc. , December 2008 , Phase 3 , Completed\,, Coronary Artery Disease , ABSORB implantation , Istituto Clinico Sant'Ambrogio ,20-Dec-13, Phase 4 , Unknown status\,,,, Nervous System Malformations , anakinra , National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) ,20-Sep-03, Phase 1 , Terminated\,,,, Parkinson Disease , [123I]B-CIT SPECT imaging , Institute for Neurodegenerative Disorders ,20-Apr-00, Phase 2 , Completed\,,,," Parkinson's Disease With End of Dose ""Wearing Off"" ", Carbidopa/levodopa/entacapone , Novartis Pharmaceuticals ,20-Jan-05, Phase 4 , Completed\,,,, Huntington Disease , ACR16 10 mg , Teva Pharmaceutical Industries ,20-Oct-08, Phase 2 , Completed\,,,, Crohn Disease , infliximab or placebo , Centocor Inc., July 2000 , Phase 3 , Completed\,,,, Crohn's Disease , Capsule endoscopy, CT enterography -  colonoscopy -  small bowel follow-through -  Mayo Clinic , January 2004 , Phase 4 , Completed\,,,, Crohn's Disease , Infliximab , Janssen Biotech Inc., November 2010 , Phase 3 , Terminated\,,,, Alzheimer Disease , [123I]AV94 , Institute for Neurodegenerative Disorders ,20-Aug-07, Phase 1 , Terminated\,,,, Alzheimer's Disease , AADvac1 , Axon Neuroscience SE ,20-Jan-14, Phase 1 , Active, not recruiting\,,, Crohn's Disease , adalimumab , Abbott ,20-Feb-07, Phase 2 , Completed\,,,, Crohn Disease , Autologous haematopoietic stem cell transplant , European Group for Blood and Marrow Transplantation , June 2006 , Phase 3 , Terminated\,,,, Lyme Disease , Permethrin , University of Minnesota - Clinical and Translational Science Institute , June 2008 , Phase 3 , Terminated\,,,, Obesity , Low glycemic load diet , Queen's University ,20-Sep-04, Phase 4 , Terminated\,,,, Crohn's Disease , Time and attention + fructo-oligosaccharide placebo , Rush University Medical Center ,20-Sep-06, Phase 1 , Completed\,,,, Parkinson's Disease , Argentinean Tango classes , McGill University Health Center ,20-Apr-12, Phase 0 , Completed\,,,, Chronic Chagas Disease, Indeterminate , E1224 -  Drugs for Neglected Diseases , June 2011 , Phase 2 , Unknown status\,,,, Idiopathic Parkinson's Disease , Rotigotine , UCB BIOSCIENCES GmbH ,20-Feb-13, Phase 4 , Completed\,,,, Alzheimer's Disease , PF-04360365 8.5 mg/kg , Pfizer ,20-May-10, Phase 1 , Completed\,,,, Crohn's Disease , Adalimumab , AbbVie ,20-Sep-13, Phase 3 , Completed\,,,, Crohn's Disease , Celebrex , University of Pittsburgh ,20-Dec-03, Phase 4 , Terminated\,,,, Alzheimer's Disease , Huperzine A , Shandong Luye Pharmaceutical Co. LTD, May 2010 , Phase 2 , Unknown status\,,,, Sickle Cell Disease , NO-CO inhalation and expiration , Assistance Publique - H\'f4pitaux de Paris ,20-Feb-08, Phase 3 , Completed\,,,, Parkinson's Disease , Levodopa/carbidopa/entacapone , Novartis ,20-Oct-06, Phase 4 , Completed\,,,, Fabry Disease , Fabrazyme (agalsidase beta) , Genzyme -  a Sanofi Company , December 2002 , Phase 2 , Terminated\,,,, Autosomal Dominant Polycystic Kidney Disease (ADPKD) , Sirolimus , Mario Negri Institute for Pharmacological Research ,20-Sep-10, Phase 2 , Terminated\,,,, Anemia of Chronic Kidney Disease , Cholecalciferol , Johns Hopkins University ,20-May-12, Phase 2 , Unknown status\,,,, Parkinson's Disease , Traditional Therapeutic Exercise , University of Indianapolis ,20-Sep-09, Phase 1 , Completed\,,,, Ischemic Heart Disease , Ad-HGF , The First Affiliated Hospital with Nanjing Medical University ,20-Nov-12, Phase 1 , Unknown status\,,,, Parkinson's Disease , placebo , IMPAX Laboratories Inc., April 2009 , Phase 3 , Completed\,,,, Hypertensive Renal Disease , USUAL - take your BP Meds as you usually do , National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,20-Nov-07, Phase 2 , Completed\,,,, Crohn's Disease , TRK-170 , Toray Industries Inc., April 2011 , Phase 2 , Completed\,,,, Parkinson Disease , Motor cortex stimulation , Assistance Publique - H\'f4pitaux de Paris ,20-Sep-05, Phase 1 , Unknown status\,,,, Gaucher Disease , GA-GCB , Shire ,20-Feb-05, Phase 1 , Completed\,,,, Pompe Disease , Clenbuterol , Dwight Koeberl M.D. - P.h.D, September 2013 , Phase 1 , Active, not recruiting\,,, Alzheimer's Disease , GSK933776 , GlaxoSmithKline ,20-May-10, Phase 1 , Completed\,,,, Huntington Disease , SEN0014196 (Low Dose) , Siena Biotech S.p.A. ,20-Mar-11, Phase 1 , Completed\,,,, Crohn's Disease , MT-1303 , Mitsubishi Tanabe Pharma Corporation ,20-Mar-15, Phase 2 , Completed\,,,, Crohn's Disease , AIN457 , Novartis Pharmaceuticals ,20-Aug-08, Phase 2 , Terminated\,,,, Celiac Disease , Prednisolone and Gluten free diet , All India Institute of Medical Sciences - New Delhi, April 2009 , Phase 2 , Completed\,,,, Parkinson Disease , Coenzyme Q10 with vitamin E , Weill Medical College of Cornell University ,20-Dec-08, Phase 3 , Terminated\,,,, Chronic Kidney Disease , Aspirin , University of Texas Southwestern Medical Center ,20-Jan-13, Phase 1 , Unknown status\,,,, Alzheimer Disease , 3APS , Bellus Health Inc , June 2004 , Phase 3 , Unknown status\,,,, Alzheimer's Disease , Dimebon , Medivation Inc., September 2005 , Phase 2 , Completed\,,,, Asthma , Chronic Disease Self-Management Online Workshop , Stanford University ,20-Jan-10, Phase 2 , Completed\,,,, Bipolar Disorder , Bipolar Disorder Program , VA Office of Research and Development , July 1997 , Phase 3 , Completed\,,,, Parkinson's Disease , Pramipexole / Rasagiline Mesylate once daily , Pharma Two B Ltd. ,20-Dec-13, Phase 2 , Active, not recruiting\,,, Parkinson Disease , Chinese exercise modalities , National Center for Complementary and Integrative Health (NCCIH) ,Jan 23 - 2002, Phase 1 , Completed\,,,, Parkinson Disease , 50 HZ Repetitive TMS , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Sep-09, Phase 1 , Completed\,,,, Crohn's Disease , Pillcam colon capsule and PillCam\'99 Prep Procedure , Given Imaging Ltd. , June 2012 , Phase 1 , Completed\,,,, Huntington Disease , minocycline , Merit Cudkowicz ,20-Apr-06, Phase 2 , Completed\,,,, Parkinson's Disease , Relaxation guided imagery , Rambam Health Care Campus ,20-May-10, Phase 0 , Completed\,,,, Parkinson's Disease , creatine , University of Rochester ,20-Mar-07, Phase 3 , Terminated\,,,, Crohns Disease , Vitamin D , University of Aarhus ,20-Sep-05, Phase 2 , Unknown status\,,,, Alzheimer Disease , DBS-f on , Functional Neuromodulation Ltd ,20-May-12, Phase 1 , Active, not recruiting\,,, Crohn's Disease , Certolizumab pegol , UCB Pharma ,20-Feb-06, Phase 3 , Completed\,,,, Inherited Metabolic Storage Diseases , CAMPATH-1H , Baylor College of Medicine , June 2002 , Phase 1 , Terminated\,,,, Coronary Heart Disease , L-Citrulline malate , Masih Daneshvari Hospital ,20-Aug-13, Phase 0 , Unknown status\,,,, Parkinson Disease , ropinirole PR/XR , GlaxoSmithKline ,20-Mar-09, Phase 3 , Completed\,,,, Crohn's Disease , Adalimumab 40 mg eow or ew , Abbott ,20-Aug-02, Phase 3 , Completed\,,,, Parkinson's Disease , Rasagiline , Teva Branded Pharmaceutical Products  R&D Inc. , November 2012 , Phase 4 , Completed\,,,, Pediatric , Second generation of colon capsule endoscopy (GIVEN IMAGING) , Azienda Policlinico Umberto I ,20-Sep-13, Phase 4 , Completed\,,,, Parkinson's Disease , levodopa-carbidopa , Osmotica Pharmaceutical US LLC ,20-Nov-07, Phase 2 , Completed\,,,, Parkinson's Disease , Rasagiline Mesylate , Teva Pharmaceutical Industries ,20-Nov-05, Phase 3 , Completed\,,,, Crohn's Disease , chondroitin sulfate , University Hospitals Cleveland Medical Center ,20-Jan-11, Phase 1 , Withdrawn\,,,, Alzheimer's Disease , LY450139 , Eli Lilly and Company ,20-Sep-08, Phase 3 , Completed\,,,, Sickle Cell Disease , Albuterol , Duke University ,20-Aug-13, Phase 1 , Completed\,,,, Alzheimer's Disease , Rivastigmine transdermal patch , Novartis Pharmaceuticals ,20-Jan-07, Phase 3 , Completed\,,,, Idiopathic Parkinson's Disease , Liatermin (r-metHuGDNF) , Amgen ,20-Mar-03, Phase 1 , Completed\,,,, Liver Disease, Alcoholic , S-adenosylmethionine - University of California Davis, September 2005 , Phase 3 , Completed\,,,, Alzheimer Disease , Far Infrared Radiation (5um to 20 umwavelength), GAAD Medical Research Institute Inc. , February 2008 , Phase 1 , Unknown status\,,,, Inherited Mitochondrial Disease, Including Leigh Syndrome , Cysteamine Bitartrate Delayed-release Capsules (RP103) -  Raptor Pharmaceuticals Inc. , June 2014 , Phase 2 , Enrolling by invitation\,,,, Alzheimer's Disease , Donepezil , Eisai Korea Inc. ,20-May-06, Phase 4 , Completed\,,,, Parkinson Disease , Tango dancing , Washington University School of Medicine , July 2009 , Phase 2 , Completed\,,,, Lung Diseases , Pulmonary rehabilitation , University of Manitoba ,20-Apr-09, Phase 1 , Completed\,,,, Graft Versus Host Disease , voriconazole , Phillip Brian Smith ,20-Dec-08, Phase 1 , Completed\,,,, Huntington's Disease , Pridopidine , Teva Branded Pharmaceutical Products  R&D Inc. , February 2014 , Phase 2 , Completed\,,,, Mild Cognitive Impairment , Flutemetamol (18F) Injection , GE Healthcare ,20-Dec-09, Phase 3 , Completed\,,,, Hodgkin's Disease , Mantle irradiation , Dana-Farber Cancer Institute ,19-May-92, Phase 2 , Completed\,,,, Peripheral Vascular Disease , Liprostin [liposomal Prostaglandin E1] , Endovasc ,20-Feb-03, Phase 2 , Unknown status\,,,, Parkinson's Disease , APL-130277 , Cynapsus Therapeutics Inc ,20-Aug-14, Phase 2 , Completed\,,,, Huntington Disease , pridopidine , Teva Branded Pharmaceutical Products  R&D Inc. ,20-Mar-05, Phase 2 , Active, not recruiting\,,, Periodontal Diseases , Treatment of periodontal disease , King Edward Memorial Hospital ,20-Oct-02, Phase 2 , Unknown status\,,,, Crohn's Disease , Semapimod , Ferring Pharmaceuticals ,20-Apr-06, Phase 2 , Completed\,,,, Crohn's Disease , Certolizumab pegol , UCB Pharma ,, Phase 3 , Completed\,,,, Alzheimer's Disease , Octohydroaminoacridine Succinate Tablets , Changchun Huayang High-tech Co., June 2011 , Phase 2 , Unknown status\,,,, Parkinson's Disease , [123I], Institute for Neurodegenerative Disorders , January 2006 , Phase 2 ,,,,, Sickle Cell Disease , Vitamin D3 ," Gary M Brittenham, MD",,, Completed\,,,, Parkinson's Disease , repetitive transcranial stimulation (r-TMS) , Sheba Medical Center ,20-Apr-08, January 2011 , Phase 1 , Completed\,,, Alzheimer's Disease , Resveratrol , Alzheimer's Disease Cooperative Study (ADCS) ,20-May-12, Phase 2 , Completed\,,,, Parkinson's Disease , Low frequency DBS of the pedunculopontine nucleus , H\'f4pital de la Salp\'e9tri\'e8re ,20-May-09, Phase 2 , Completed\,,,, Parkinson's Disease , TCH346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt) , Phase 1 , Completed\,,,, Crohn's Disease , D9421-C, 9mg , AstraZeneca , Novartis , January 2002 , Phase 1 , Completed\,, Crohn's Disease , AMG 139 , Amgen ,20-Feb-11, October 2006 , Phase 2 , Completed\,,, Huntington's Disease , AFQ056 , Novartis Pharmaceuticals ,20-Nov-09, Phase 1 , Completed\,,,, Alzheimer Disease , [18F]-FEPPA , Institute for Neurodegenerative Disorders ,20-Aug-09, Phase 2 , Terminated\,,,, Crohn's Disease , Delayed Release 6MP or Calcitriol vs. Purinethol , Teva GTC , July 2006 , Phase 1 , Completed\,,,, Gastroesophageal Reflux Disease , Laparoscopic Nissen Fundoplication , Chinese University of Hong Kong ,20-Nov-06, Phase 1 , Completed\,,,, Alzheimer's Disease , Standard intervention protocol , University Hospital, Bordeaux , Phase 3 , Unknown status\,,,, Crohn's Disease , THC 5 mg/ml and CBD 50 mg/ml. , Meir Medical Center ,20-Mar-13, March 2008 , Phase 3 , Completed\,,, Crohn's Disease , certolizumab pegol 400 mg , UCB Pharma ,20-Nov-06, Phase 1 , Unknown status\,,,, Crohn's Disease , VSL#3 , Samsung Medical Center ,20-Jan-10, Phase 3 , Terminated\,,,, Ischemic Heart Disease , coronary artery bypass grafting with administration of autologous bone marrow stem cells , St. Petersburg State Pavlov Medical University ,20-Feb-13, Phase 3 , Unknown status\,,,, Parkinson's Disease , Istradefylline (KW-6002) , Kyowa Hakko Kirin Company, Limited , Phase 3 , Active, not recruiting\,,, Peripheral Blood Stem Cell Transplantation , PBMC Transplant , National Heart, Lung, November 2005 , Phase 2 , Completed\,,, Inflammatory Bowel Disease , Home Monitoring , University of Maryland ,20-Sep-12, and Blood Institute (NHLBI) , September 2009 , Phase 1 , Active, not recruiting\, Chronic Granulomatous Disease , retroviral SF71-gp91phox transduced CD34+ cells , University of Zurich , June 2004 , Phase 3 , Active, not recruiting\,,, Alzheimer Disease , [18F] MNI-558 , Institute for Neurodegenerative Disorders ,20-Sep-10, Phase 1 , Completed\,,,, Chagas Disease , Exercise, nutritional and pharmaceutical counceling , Evandro Chagas National Institute of Infectious Disease , Phase 0 , Completed\,,,, Alzheimer's Disease , Rivastigmine , Novartis Pharmaceuticals ,20-Aug-14, March 2015 , Phase 3 , Active, not recruiting\,, Alzheimer Disease , alphatocopherol , University of Kentucky ,20-May-02, Phase 4 , Completed\,,,, Pompe Disease , rAAV1-CMV-GAA (study agent) Administration , University of Florida ,20-Sep-10, Phase 3 , Unknown status\,,,, Crohn's Disease , CCX282-B , ChemoCentryx ,20-Mar-06, Phase 1 , Completed\,,,, Alzheimer's Disease , Varenicline , Pfizer , July 2009 , Phase 2 , Completed\,,,, Crohn's Disease , Prochymal\'99 adult human mesenchymal stem cells , Mesoblast International S\'e0rl ,20-Feb-06, Phase 2 , Completed\,,,, Alzheimer Disease , SPECT scan , Institute for Neurodegenerative Disorders ,20-Aug-07, Phase 2 , Completed\,,,, Crohn's Disease , IMURAN (azathioprine) , National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,20-Feb-05, Phase 1 , Terminated\,,,, Pompe Disease , Albuterol , Duke University , June 2013 , Phase 2 , Terminated\,,,, Alzheimer Disease , MNI-513-01 , Institute for Neurodegenerative Disorders ,20-Oct-09, Phase 1 , Active, not recruiting\,,, Crohn Disease , Sargramostim (Leukine) , Genzyme, a Sanofi Company , Phase 0 , Terminated\,,,, Crohn Disease , FDG PET/CT , Universit\'e9 de Sherbrooke ,20-Sep-06, February 2003 , Phase 2 , Terminated\,,, Parkinson's Disease , NTCELL , Living Cell Technologies , July 2013 , Phase 2 , Unknown status\,,,, Inflammatory Bowel Disease , Fecal microbial l transplantation , Meir Medical Center ,20-Apr-15, Phase 1 , Completed\,,,, Alzheimer's Disease , EVP-6124 , FORUM Pharmaceuticals Inc ,20-Apr-10, Phase 1 , Terminated\,,,, Chronic Graft-versus-host Disease , Bortezomib , Baylor Research Institute , June 2010 , Phase 2 , Completed\,,,, Charcot Marie Tooth Disease , Coenzyme Q10 , Memorial Medical Center ,20-Sep-07, Phase 2 , Active, not recruiting\,,, Hodgkin's Disease , R-mabHD , American Scitech International , July 2011 , Phase 1 , Completed\,,,, Hematologic Malignancies , reduced intensity, related donor stem cell transplant , Pavan Reddy, Phase 2 , Unknown status\,,,, Crohn's Disease , Dehydroepiandrosterone [DHEA] , Inflabloc Pharmaceuticals ,20-Jan-05, MD , January 2009 , Phase 1 , Completed\,, Parkinson's Disease , Exelon Patch (rivastigmine transdermal system) , University of Pennsylvania ,20-Dec-11, Phase 2 , Completed\,,,, Celiac Disease , AT-1001 , Alba Therapeutics ,20-Aug-07, Phase 4 , Completed\,,,, Crohn's Disease , Allogeneic Stem Cell Therapy , Northwestern University ,20-Jan-10, Phase 2 , Completed\,,,, Alzheimer Disease , Dimebon 20 mg po TID , Pfizer ,20-Sep-09, Phase 1 , Terminated\,,,, HIV Disease , ,,, Phase 3 , Terminated\,,,,\f1 \uc0\u945 ,,,,,,,,,\f0 1 Proteinase Inhibitor , Institute for Human Genetics and Biochemistry , April 2012 , Phase 2 ,,,,,, Crohn's Disease , smoking of cannabis , Meir Medical Center ,20-Jan-10, Terminated\,,,,, Systemic Lupus Erythematosus , Group B SLE one blood donation , Oklahoma Medical Research Foundation ,20-May-09, Phase 1 , Unknown status\,,,, Crohn's Disease , TA-650 , Mitsubishi Tanabe Pharma Corporation ,20-Dec-08, Phase 1 , Completed\,,,, Sickle Cell Disease , Ticagrelor , AstraZeneca , July 2015 , Phase 3 , Completed\,,,, Huntington's Disease , Creatine , National Center for Complementary and Integrative Health (NCCIH) ,20-Oct-01, Phase 2 , Active, not recruiting\,,, ISCHEMIC CARDIOMYOPATHY , 'SEEMORE' - MANGANESE-ENHANCED MRI CONTRAST REAGENT , Stanford University ,20-May-13, Phase 1 , Completed\,,,, Parkinson's Disease , MitoQ , Antipodean Pharmaceuticals, Inc. , Phase 1 , Completed\,,,, Idiopathic Parkinson's Disease , Deep Brain Stimulation , Boston Scientific Corporation ,20-Oct-10, May 2006 , Phase 2 , Completed\,,, Alzheimer's Disease , Human Umbilical Cord Derived MSC , Affiliated Hospital to Academy of Military Medical Sciences ,20-Mar-12, Phase 2 , Active, not recruiting\,,, Crohn's Disease , Certolizumab pegol , UCB Pharma ,20-Apr-07, Phase 1 , Active, not recruiting\,,, Parkinson Disease , Group singing , Johns Hopkins University ,20-Dec-15, Phase 3 , Terminated\,,,, Chronic Kidney Disease , Electronic Decision Support , Brigham and Women's Hospital ,20-May-11, Phase 2 , Active, not recruiting\,,, Alzheimer's Disease , HF0220 , Hunter-Fleming Ltd , July 2006 , Phase 3 , Completed\,,,, Alzheimer's Disease , AH110690 (18F) Injection , GE Healthcare ,20-Sep-08, Phase 2 , Completed\,,,, Peyronie's Disease , AA4500 , Endo Pharmaceuticals ,20-Nov-10, Phase 2 , Completed\,,,, Alzheimer's Disease , TRx0237 150 mg/day , TauRx Therapeutics Ltd ,20-Jan-13, Phase 3 , Completed\,,,, Type I Gaucher Disease , Ambroxol , Exsar Corporation ,20-Dec-12, Phase 3 , Completed\,,,, Crohn's Disease , STA-5326 , National Institute of Allergy and Infectious Diseases (NIAID) ,20-Nov-05, Phase 1 , Suspended\,,,, Parkinson's Disease , Respiratory muscle strength training , University of Florida ,20-Dec-04, Phase 2 , Completed\,,,, Crohn's Disease , Certolizumab Pegol (CDP870) , UCB Pharma ,20-Feb-04, Phase 2 , Completed\,,,, Fabry Disease , Lucerastat , Actelion ,20-Feb-15, Phase 3 , Completed\,,,, Pulmonary Disease, Chronic Obstructive , Placebo , MedImmune LLC , Phase 1 , Completed\,,,, Crohn's Disease , AIN457 , Novartis Pharmaceuticals ,20-Oct-09, November 2010 , Phase 2 , Completed\,,, Celiac Disease , AT1001 , Alba Therapeutics ,20-Aug-06, Phase 2 , Terminated\,,,, Celiac Disease , Larazotide Acetate 0.5 mg , Alba Therapeutics ,20-Oct-11, Phase 2 , Completed\,,,, Crohn's Disease , J695 , National Institute of Allergy and Infectious Diseases (NIAID) ,20-Dec-00, Phase 2 , Completed\,,,, Crohn's Disease , Visilizumab , Facet Biotech ,20-Feb-05, Phase 1 , Completed\,,,, Kidney Disease , Whole Body Vibration , Universidade Federal de Pernambuco ,20-Apr-15, Phase 2 , Completed\,,,, Fibrosis , Pirfenidone , University of Guadalajara ,20-Sep-09, Phase 4 , Completed\,,,, Alzheimer's Disease , ST101 , Sonexa Therapeutics, Inc. , Phase 1 , Completed\,,,, Crohn Disease , UVADEX and UVAR XTS Photopheresis System , National Institute of Allergy and Infectious Diseases (NIAID) ,20-Mar-03, February 2009 , Phase 2 , Completed\,,, Alzheimer's Disease , Insulin Aspart , Jeff Burns, MD , Phase 1 , Completed\,,,, Graft Vs Host Disease , ABX-CBL , Abgenix ,19-Oct-99, October 2007 , Phase 1 , Completed\,,, Peyronie's Disease , AA4500 , Endo Pharmaceuticals ,20-Sep-12, Phase 2 , Completed\,,,, Parkinson Disease , Cognitive Behavioral Therapy , Michael Debakey Veterans Affairs Medical Center ,20-Nov-11, Phase 3 , Completed\,,,, Crohn's Disease , Infliximab , Samsung Medical Center ,20-Oct-09, Phase 1 , Completed\,,,, Meniere's Disease , Methylprednisolone , Imperial College London ,20-Apr-09, Phase 3 , Completed\,,,, Hodgkins Disease , Proton , Indiana University ,20-Sep-11, Phase 2 , Completed\,,,, Kidney Disease , Propranolol , University of California, San Francisco , Phase 0 , Terminated\,,,, Parkinson's Disease , Istradefylline , Kyowa Hakko Kirin Company, Limited , March 2010 , Phase 1 , Completed\,,, Crohn's Disease , azathioprine , Massachusetts General Hospital ,20-Apr-05, March 2007 , Phase 2 , Completed\,,, Neurodegenerative Disease , dextromethorphan , National Institute of Neurological Disorders and Stroke (NINDS) , July 1993 , Phase 3 , Terminated\,,,, Alzheimer's Disease , ST101 , Sonexa Therapeutics, Inc. , Phase 2 , Completed\,,,, Crohn's Disease , Sargramostim (Leukine) , Genzyme, a Sanofi Company , February 2009 , Phase 2 , Completed\,,, Cardiovascular Disease , Polypill: Red Heart Pill , Imperial College London ,20-Feb-11, June 2006 , Phase 2 , Terminated\,,, Parkinson's Disease , Vitamin B12 Supplementation , Emory University ,20-Sep-06, Phase 3 , Completed\,,,, Alzheimer Disease , BI 425809 dose 1 , Boehringer Ingelheim ,20-Aug-16, Phase 2 , Terminated\,,,, Parkinson's Disease , deep brain stimulation (ACTIVA PC, Medtronic) , University Hospital Tuebingen , Phase 2 , Suspended\,,,, Meniere's Disease , Famciclovir , House Research Institute ,20-Dec-11, February 2011 , Phase 2 , Completed\,,, Alzheimer's Disease , saracatinib , Stephen M. Strittmatter , July 2013 , Phase 3 , Terminated\,,,, Alzheimer Disease , [123I]-IBVM , Institute for Neurodegenerative Disorders ,20-Feb-07, Phase 1 , Completed\,,,, Alzheimer's Disease , Sertraline (Zoloft) , Johns Hopkins University , July 2004 , Phase 2 , Completed\,,,, End Stage Renal Disease , 13-valent conjugate pneumococcal vaccine , Michigan State University ,20-May-13, Phase 2 , Completed\,,,, Parkinson Disease , Real iTBS , Mark Hallett ,20-Sep-08, Phase 4 , Completed\,,,, Parkinson's Disease , IV Levodopa , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Mar-01, Phase 1 , Completed\,,,, Sickle Cell Disease , GMI-1070 , Pfizer ,20-May-09, Phase 2 , Completed\,,,, Panic Disorder , PFPP , Weill Medical College of Cornell University ,20-Feb-00, Phase 1 , Completed\,,,, Parkinson's Disease , bone marrow derived mesenchymal stem cells , Guangzhou General Hospital of Guangzhou Military Command ,20-Oct-11, Phase 2 , Completed\,,,, Ulcerative Colitis , Bifidobacterium infantis 35624 , University College Cork ,20-Jan-02, Phase 1 , Unknown status\,,,, Alzheimer's Disease , TRx0014 , TauRx Therapeutics Ltd , July 2007 , Phase 2 , Unknown status\,,,, Alzheimer Disease , Raloxifene , University of Wisconsin, Madison , Phase 2 , Completed\,,,, Parkinson's Disease , Istradefylline (KW-6002) , Kyowa Kirin Pharmaceutical Development, Inc. , September 2001 , Phase 2 , Completed\,,, Graft vs Host Disease , intra-arterial treatment , Hadassah Medical Organization ,20-Dec-00, June 2004 , Phase 3 , Completed\,,, Parkinson Disease , tDCS , Universidade Federal de Pernambuco ,20-Jan-10, Phase 1 , Completed\,,,, Alzheimer's Disease , MABT5102A , Genentech, Inc. , Phase 2 , Completed\,,,, Parkinson's Disease , duloxetine , University Hospital, Toulouse , April 2011 , Phase 2 , Completed\,,, Parkinson's Disease , Glutathione , University of South Florida ,20-Sep-03, May 2011 , Phase 3 , Unknown status\,,, Alzheimer's Disease , Rivastigmine transdermal patch , Novartis Pharmaceuticals ,20-Mar-12, Phase 2 , Completed\,,,, Gaucher's Disease , CEREDASE\'99 , National Institute of Neurological Disorders and Stroke (NINDS) ,19-Dec-93, Phase 4 , Completed\,,,, Alzheimer Disease , [123I] IMPY & SPECT Imaging , Institute for Neurodegenerative Disorders ,20-Feb-06, Phase 2 , Completed\,,,, Celiac Disease , Necator americanus , The Prince Charles Hospital ,20-Aug-12, Phase 1 , Completed\,,,, Idiopathic Parkinson Disease , Levetiracetam , UCB Pharma , July 2003 , Phase 1 , Completed\,,,, Parkinson's Disease , Rasagiline , Teva Neuroscience, Inc. , Phase 2 , Completed\,,,, Parkinson's Disease , Oxaloacetate (OAA) , University of Kansas Medical Center ,20-Dec-12, December 2009 , Phase 4 , Completed\,,, Alzheimer's Disease , Rivastigmine transdermal patch , Novartis Pharmaceuticals , July 2008 , Phase 2 , Completed\,,,, Alzheimer's Disease , Resveratrol with Glucose, and Malate , VA Office of Research and Development , Phase 4 , Completed\,,,, Alzheimer's Disease , EVP-6124 (0.1 mg/day) , FORUM Pharmaceuticals Inc ,20-Oct-08, January 2008 , Phase 3 , Completed\,,, Parkinson's Disease , Istradefylline (KW-6002) , Kyowa Hakko Kirin Company, Limited , Phase 1 , Completed\,,,, Periodontal Diseases , Active Comparator:Aloe Vera mouthwash , Islamic Azad University, Tehran , April 2005 , Phase 2 , Completed\,,, Graft-Versus-Host Disease , Mesenchymal stromal cells , Karolinska Institutet ,20-Aug-11, March 2014 , Phase 2 , Completed\,,, Parkinson's Disease , Coenzyme Q10 Nanodispersion (Nanoquinone) , Technische Universit\'e4t Dresden ,20-Sep-03, Phase 1 , Active, not recruiting\,,, Crohn's Disease , Delayed Release 6 mercaptopurine , Teva GTC ,20-Nov-10, Phase 3 , Completed\,,,, Crohn's Disease , Labeling Ceretec , GlaxoSmithKline ,20-Jan-10, Phase 1 , Terminated\,,,, Parkinson's Disease , Coenzyme Q10 , National Institute of Neurological Disorders and Stroke (NINDS) ,19-Sep-98, Phase 1 , Completed\,,,, Parkinson's Disease , BIIB014 , Biogen ,20-Apr-07, Phase 2 , Completed\,,,, Sickle Cell Disease , N-Acetylcysteine , Bloodworks (Puget Sound Blood Center) ,20-Mar-13, Phase 2 , Completed\,,,, Alzheimer's Disease , I123MNI388/I123MNI390 , Institute for Neurodegenerative Disorders ,20-Mar-09, Phase 1 , Enrolling by invitation\,,,, Chronic Granulomatous Disease , Nexell Isolex with T-cell Depletion , National Institute of Allergy and Infectious Diseases (NIAID) ,19-Apr-98, Phase 1 , Terminated\,,,, Crohn's Disease , Olokizumab (OKZ) , UCB BIOSCIENCES GmbH , June 2012 , Phase 1 , Completed\,,,, Chronic Granulomatous Disease , T-Cell Depleted & CD34+Select/w/StemCell Enriched Product , National Institute of Allergy and Infectious Diseases (NIAID) ,20-Aug-01, Phase 2 , Withdrawn\,,,, Chronic Kidney Disease , Mablet 360 mg , Zealand University Hospital ,20-Aug-14, Phase 3 , Completed\,,,, Parkinson's Disease , NS2330 , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Aug-00, Phase 1 , Completed\,,,, Muckle Wells Syndrome , XOMA 052 , National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) ,20-Aug-10, Phase 2 , Completed\,,,, Crohn's Disease , Adacolumn , Otsuka America Pharmaceutical ,20-Jan-05, Phase 1 , Withdrawn\,,,, Parkinson's Disease , SPM 962 , Otsuka Pharmaceutical Co. Ltd, August 2006 , Phase 3 , Completed\,,,, Parkinson's Disease , deep brain stimulation , University of Minnesota - Clinical and Translational Science Institute , June 1999 , Phase 2 , Completed\,,,, Periodontal Diseases , Triclosan , Colgate Palmolive ,20-Nov-00, Phase 3 , Completed\,,,, Crohn's Disease , Visilizumab , Facet Biotech ,20-Feb-05, Phase 3 , Unknown status\,,,, Alzheimer's Disease , TRx0237 200 mg/day , TauRx Therapeutics Ltd ,20-Oct-12, Phase 2 , Completed\,,,, Parkinson's Disease , Carbidopa/levodopa/entacapone , Novartis Pharmaceuticals ,20-Sep-04, Phase 3 , Completed\,,,, Von Willebrand Disease , Biostate , CSL Behring ,20-Aug-10, Phase 3 , Completed\,,,, Huntington's Disease , Music Therapy , University of Rochester , July 2004 , Phase 3 , Completed\,,,, Alzheimer's Disease , Solanezumab , Eli Lilly and Company , July 2013 , Phase 1 , Completed\,,,, Parkinson`s Disease , VIUSID/ALZER , Catalysis SL ,20-Oct-09, Phase 3 , Active, not recruiting\,,, Chronic Granulomatous Disease , interferon-gamma , National Institute of Allergy and Infectious Diseases (NIAID) ,19-May-92, Phase 3 , Completed\,,,, Crohn's Disease , MEDI2070 , AstraZeneca ,20-Feb-13, Phase 4 , Completed\,,,, Crohn's Disease , ABT-494 , AbbVie ,20-Mar-15, Phase 2 , Active, not recruiting\,,, Inflammatory Bowel Disease (IBD) , SC12267 (4SC-101) , 4SC AG ,20-Mar-09, Phase 2 , Active, not recruiting\,,, Alzheimer Disease , lecozotan SR (SRA-333) , Wyeth is now a wholly owned subsidiary of Pfizer ,20-Mar-06, Phase 2 , Completed\,,,, Parkinson Disease , IV Levodopa , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Apr-05, Phase 2 , Completed\,,,, Alzheimer Disease , Simvastatin , National Institute on Aging (NIA) ,20-Dec-02, Phase 2 , Completed\,,,, Parkinson's Disease Dementia , Rivastigmine capsule , Novartis ,20-Jan-08, Phase 3 , Completed\,,,, Crohn's Disease , Placebo , Mesoblast International S\'e0rl ,20-Oct-07, Phase 3 , Completed\,,,, Parkinson's Disease , Activa PC+S , University of Minnesota - Clinical and Translational Science Institute ,20-May-16, Phase 3 , Completed\,,,, Body Dysmorphic Disorder , Levetiracetam , Butler Hospital ,20-Dec-04, Phase 0 , Enrolling by invitation\,,,, Coronary Artery Disease , PB127 for Injectable Suspension , Point Biomedical ,20-Oct-07, Phase 4 , Completed\,,,, Crohn's Disease , Probiotic , The Baruch Padeh Medical Center - Poriya, February 2013 , Phase 3 , Terminated\,,,, Parkinson's Disease , ProSavin , Oxford BioMedica ,20-Jan-08, Phase 4 , Unknown status\,,,, Crohn's Disease , autologous mesenchymal stromal cell , Emory University , July 2012 , Phase 1 , Completed\,,,, Influenza Disease , Adjuvanted influenza vaccine , Novartis Vaccines ,20-Nov-06, Phase 1 , Completed\,,,, Hand, Foot and Mouth Disease -  Magnesium Sulphate,  Oxford University Clinical Research Unit - Vietnam, April 2014 , Phase 3 , Completed\,,,, Idiopathic Parkinson's Disease , CD-LD ER , IMPAX Laboratories Inc., October 2005 , Phase 2 , Unknown status\,,,, Parkinson's Disease , Deferiprone , Imperial College London ,20-Feb-12, Phase 1 , Completed\,,,, Kawasaki Disease , Sestamibi , Lantheus Medical Imaging ,20-Aug-05, Phase 2 , Unknown status\,,,, Chronic Granulomatous Disease , Stem cell transplantation , National Institute of Allergy and Infectious Diseases (NIAID) ,20-Oct-00, Phase 3 , Completed\,,,, Parkinson Disease , Gait tests with and without the use of a tactile sensory cue (electrical stimulation using a TENS unit) , Washington University School of Medicine ,20-May-08, Phase 2 , Completed\,,,, Chronic Obstructive Pulmonary Disease , Cholecalciferol , Barts & The London NHS Trust ,20-Sep-09, Phase 0 , Terminated\,,,, Coronary Artery Disease , Perfusion CMR for detection of coronary artery disease , Amersham Buchler - GmbH & Co KG , July 2003 , Phase 2 , Completed\,,,, Chronic Granulomatous Disease , Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells , National Institute of Allergy and Infectious Diseases (NIAID) ,20-Oct-06, Phase 3 , Completed\,,,, Von Willebrand Disease , Biostate , CSL Behring ,20-Oct-10, Phase 0 , Terminated\,,,, Alzheimer's Disease , AChEI - Either donepezil or galantamine or rivastigmine with or without memantine , Hoffmann-La Roche ,20-Oct-12, Phase 3 , Completed\,,,, Kidney, Polycystic , Lisinopril  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) , January 2006 , Phase 2 , Completed\,,,, Crohn's Disease , 23-valent polysaccharide pneumococcal vaccine , Kyunghee University Medical Center ,20-Dec-11, Phase 3 , Completed\,,,, Parkinson Disease , Zonisamide , Mazandaran University of Medical Sciences ,20-Feb-13, Phase 4 , Completed\,,,, Pediatric Crohn's Disease , Top-down , University of Roma La Sapienza ,20-Dec-12, Phase 2 , Unknown status\,,,, Alzheimer's Disease , Rivastigmine Patch , Novartis Pharmaceuticals , July 2011 , Phase 4 , Withdrawn\,,,, Parkinson's Disease , ADX48621 , Addex Pharma S.A. ,20-Apr-11, Phase 3 , Completed\,,,, Parkinson's Disease , Cranial Electric Stimulation (CES) , University of Maryland ,20-Jan-10, Phase 2 , Completed\,,,, Alzheimer's Disease , ACC-001 (vanutide cridificar) , JANSSEN Alzheimer Immunotherapy Research & Development LLC, January 2011 , Phase 1 , Completed\,,,, Cushing Disease , Pasireotide , Novartis Pharmaceuticals ,20-Aug-04, Phase 2 , Completed\,,,, Parkinson Disease , [123I]B-CIT , Institute for Neurodegenerative Disorders ,20-Jan-06, Phase 2 , Completed\,,,, Fabry Disease , Replagal (Agalsidase Alfa) , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Nov-04, Phase 2 , Completed\,,,, Alzheimer's Disease , Tamibarotene , Osaka City University ,20-May-10, Phase 4 , Completed\,,,, Parkinson's Disease , sNN0031 , Newron Sweden AB ,20-Mar-09, Phase 2 , Unknown status\,,,, Crohn's Disease , Autologous Stem Cell Transplantation , Northwestern University ,20-Apr-05, Phase 1 , Completed\,,,, Crohn's Disease , ERB-041 , Wyeth is now a wholly owned subsidiary of Pfizer ,20-Apr-04, Phase 2 , Terminated\,,,, Celiac Disease , STAN1 , Heim Pal Children's Hospital ,20-Aug-08, Phase 1 , Completed\,,,, Nonalcoholic Fatty Liver Disease (NAFLD) , DR cysteamine bitartrate capsule , National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) , June 2012 , Phase 1 , Active, not recruiting\,,, Alzheimer's Disease , Nilvadipine , Prof Brian Lawlor ,20-Oct-12, Phase 2 , Completed\,,,, Crohn's Disease , Semapimod , Ferring Pharmaceuticals ,20-Dec-02, Phase 3 , Active, not recruiting\,,, Huntington's Disease , Lithium , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Oct-04, Phase 2 , Completed\,,,, Parkinson's Disease , ODM-101 65mg Carbidopa , Orion Corporation -  Orion Pharma , May 2011 , Phase 2 , Completed\,,,, Crohn's Disease , CP-461 , Astellas Pharma Inc , July 2002 , Phase 2 , Completed\,,,, Parkinson's Disease , Istradefylline (KW-6002) , Kyowa Kirin Pharmaceutical Development Inc., March 2002 , Phase 2 , Completed\,,,, Alzheimer's Disease , Interferon beta-1a , Merck KGaA ,20-Nov-04, Phase 2 , Completed\,,,, Parkinson's Disease , Caffeine , McGill University Health Center ,20-Apr-14, Phase 2 , Completed\,,,, Panic Disorder , Duloxetine , Massachusetts General Hospital ,20-Aug-06, Phase 3 , Active, not recruiting\,,, Parkinson's Disease , Donepezil , Newcastle-upon-Tyne Hospitals NHS Trust ,20-Jan-13, Phase 4 , Completed\,,,, Alzheimer's Disease , ABT-288 , AbbVie (prior sponsor Abbott), December 2009 , Phase 3 , Suspended\,,,, Chronic Kidney Disease , Sodium bicarbonate , Albert Einstein College of Medicine of Yeshiva University ,20-Mar-09, Phase 2 , Completed\,,,, Sickle Cell Disease , Codeine (30 mg) , PriCara -  Unit of Ortho-McNeil Inc., March 2005 , Phase 2 , Completed\,,,, Parkinson's Disease , Rotigotine , UCB Pharma , July 2007 , Phase 1 , Completed\,,,, Coronary Disease , torcetrapib/atorvastatin , Pfizer , July 2004 , Phase 3 , Terminated\,,,, Arterial Occlusive Diseases , intraarterial stem cell therapy , Johann Wolfgang Goethe University Hospital ,20-Oct-05, Phase 3 , Terminated\,,,, Fabry Disease , Replagal , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Oct-03, Phase 1 , Completed\,,,, Fabry Disease , Replagal , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Jan-04, Phase 2 , Completed\,,,, Kawasaki Disease , Infliximab , Fudan University ,20-Jan-13, Phase 2 , Completed\,,,, Parkinson's Disease , EMD 128130 , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Jan-01, Phase 3 , Completed\,,,, Crohn's Disease , TNFa Kinoid , Neovacs ,20-Oct-08, Phase 2 , Completed\,,,, Peripheral Arterial Disease , Atorvastatin , Hospital Universitario Getafe ,20-Jan-08, Phase 1 , Completed\,,,, Crohn's Disease , Certolizumab pegol (CZP) , UCB Japan Co. Ltd. ,20-May-06, Phase 4 , Completed\,,,, Parkinson's Disease , Caffeine 100-200 mg BID , Ron Postuma ,20-Apr-07, Phase 2 , Completed\,,,, Inflammatory Bowel Diseases (IBD) , Fecal Microbiota Transplantation (FMT) , University of Pittsburgh ,20-Sep-14, Phase 2 , Completed\,,,, Type 2 Diabetes , Diabetes and depression intervention , National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,20-Oct-09, Phase 1 , Active, not recruiting\,,, Liver Disease , Fresh Frozen Plasma , University of Colorado - Denver, January 2012 , Phase 4 , Unknown status\,,,, Parkinson Disease , JP 1730 , National Institute of Neurological Disorders and Stroke (NINDS) , June 2002 , Phase 4 , Active, not recruiting\,,, Mild Alzheimer's Disease , Sodium Oxybate , Clayton Sleep Insititute , June-24-2008, Phase 2 , Completed\,,,, Alzheimer's Disease , VI-1121 , VIVUS Inc., August 2011 , Phase 4 , Terminated\,,,, Graft vs. Host Disease , Ustekinumab , H. Lee Moffitt Cancer Center and Research Institute ,20-Feb-13, Phase 2 , Completed\,,,, Peyronie's Disease , AA4500 , Endo Pharmaceuticals ,20-Sep-10, Phase 2 , Active, not recruiting\,,, Ocular Surface Disease , Fishoil supplement , University of Illinois at Chicago ,20-Apr-12, Phase 3 , Completed\,,,, Gastroesophageal Reflux Disease , mosapride for the first month and placebo for the 2nd month , Lotung Poh-Ai Hospital , June 2008 , Phase 0 , Unknown status\,,,, Parkinson's Disease With Cognitive Impairments , safinamide , Newron ,20-Sep-10, Phase 4 , Completed\,,,, End-stage Renal Disease , Calcium carbonate ( Intensive phosphate control) , St. Michael's Hospital - Toronto, January 2014 , Phase 2 , Completed\,,,, Alzheimer's Disease , PF-04447943 , Pfizer ,20-Sep-09, Phase 2 , Completed\,,,, Parkinson's Disease , Reduced Glutathione 100mg , Bastyr University ,20-Apr-15, Phase 2 , Completed\,,,, Parkinson's Disease , IPX066 , IMPAX Laboratories Inc., September 2009 , Phase 2 , Completed\,,,, Alzheimer's Disease , DAOI-B , Chang Gung Memorial Hospital ,20-Jan-12, Phase 3 , Completed\,,,, Alzheimer's Disease , CERE-110: Adeno-Associated Virus Delivery of NGF , Ceregene , June 2004 , Phase 2 , Completed\,,,, Celiac Disease , ALV003 , Alvine Pharmaceuticals Inc. ,20-Nov-10, Phase 1 , Completed\,,,, Parkinson's Disease , Methylphenidate , Laval University ,20-Dec-10, Phase 2 , Completed\,,,, Alzheimer Disease , Divalproex , National Institute of Neurological Disorders and Stroke (NINDS) , July 2004 , Phase 4 , Terminated\,,,, Chronic Obstructive Pulmonary Disease , BiPAP Pro 2, Phillips Respironics -  National Institute of Respiratory Diseases - Mexico, December 2011 , Phase 2 , Completed\,,,, Alzheimer's Disease , ABT-384 , AbbVie (prior sponsor Abbott), May 2010 , Phase 4 , Active, not recruiting\,,, Mitochondrial Diseases , Cysteamine Bitartrate Delayed-release Capsules , Raptor Pharmaceuticals Inc. ,20-May-15, Phase 2 , Completed\,,,, Sickle Cell Disease , Alternative donor bone marrow and cord blood , Emory University ,20-Jan-06, Phase 2 , Enrolling by invitation\,,,, Crohn's Disease , Interferon beta-1a , EMD Serono ,20-Nov-01, Phase 0 , Terminated\,,,, Diverticular Disease of the Colon , Mesalazine plus Lactobacillus casei , Hospital Cristo Re ,20-Jan-09, Phase 2 , Terminated\,,,, Parkinson Disease , ropinirole monotherapy , GlaxoSmithKline ,20-Jan-12, Phase 4 , Completed\,,,, Parkinson Disease , Botulinum Toxin Type A , University of Cincinnati ,20-May-07, Phase 4 , Completed\,,,, Fabry Disease , DRX005B , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Nov-02, Phase 4 , Terminated\,,,, Peyronie's Disease , AA4500 , Endo Pharmaceuticals ,20-Oct-10, Phase 2 , Completed\,,,, Parkinson's Disease , ROZEREM , Southern California Institute for Research and Education , June 2007 , Phase 3 , Completed\,,,, Chronic Kidney Disease , Diet and exercise , The Cleveland Clinic ,20-Aug-10, Phase 4 , Terminated\,,,, Chronic Granulomatous Disease , VM106 , ViroMed Co.  Ltd. dba VM BioPharma, January 2007 , Phase 2 , Completed\,,,, Alzheimer\'b4s Disease , Immune Globulin Intravenous (Human), 10% Solution  Baxalta US Inc., January 2012 , Phase 1 , Active, not recruiting\,,, Alzheimer's Disease , Individualized management of AD including caregiver training , New York University School of Medicine ,20-Aug-06, Phase 3 , Terminated\,,,, Huntington's Disease (HD) , Creatine monohydrate , Massachusetts General Hospital ,20-Apr-05, Phase 4 , Completed\,,,, Alzheimer Disease , Sodium oligo-mannurarate 600mg , Shanghai Greenvalley Pharmaceutical Co. Ltd, October 2011 , Phase 2 , Completed\,,,, Alcohol-related Disorders , Couple-Based Treatment for Alcohol Use Disorders and PTSD , VA Office of Research and Development ,20-Aug-10, Phase 2 , Completed\,,,, Celiac Disease , ALV003 , Alvine Pharmaceuticals Inc. ,20-Aug-09, Phase 1 , Completed\,,,, Inflammatory Bowel Diseases , PET-CT , University of Wisconsin - Madison, October 2004 , Phase 2 , Completed\,,,, Meniere's Disease , OTO-104 , Otonomy Inc., November 2013 , Phase 4 , Terminated\,,,, Parkinson's Disease , Atomoxetine , Medical University of South Carolina ,20-Nov-12, Phase 2 , Completed\,,,, Alzheimer's Disease , Panax Ginseng , Seoul National University Hospital ,20-Apr-04, Phase 2 , Completed\,,,, Parkinson Disease , Donepezil , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Feb-02, Phase 1 , Completed\,,,, HIV Infection Associated Kaposi Disease , Lenalidomide , French National Agency for Research on AIDS and Viral Hepatitis ,20-Oct-11, Phase 4 , Completed\,,,, Crohn's Disease , STA-5326 mesylate , Synta Pharmaceuticals Corp. ,20-Aug-05, Phase 2 , Terminated\,,,, Peripheral Arterial Disease (PAD) , clopidogrel (SR25990) , Sanofi ,20-Feb-09, Phase 2 , Completed\,,,, Addison's Disease , Solu-Cortef (hydrocortisone) , Haukeland University Hospital ,20-Feb-10, Phase 3 , Completed\,,,, Obstructive Sleep Apnea , Conservative Medical Therapy , Brigham and Women's Hospital ,20-Mar-11, Phase 2 , Completed\,,,, Chronic Kidney Disease , multidisciplinary predialysis education , Chang Gung Memorial Hospital , July 2007 , Phase 2 , Unknown status\,,,, Coronary Heart Disease , Xuesaitong soft capsule , Guang'anmen Hospital of China Academy of Chinese Medical Sciences ,20-May-12, Phase 4 , Completed\,,,, Crohn's Disease , VSL#3 , Orphan Australia , June 2005 , Phase 2 , Unknown status\,,,, Chronic Kidney Disease , Sitaxsentan , University of Edinburgh ,20-May-07, Phase 4 , Completed\,,,, Graft Versus Host Disease , Palifermin , Swedish Orphan Biovitrum ,20-Dec-05, Phase 2 , Unknown status\,,,, Pediatric , COPP/ABV , Memorial Sloan Kettering Cancer Center ,19-Mar-96, Phase 2 , Completed\,,,, Coronary Heart Disease , Ateronon , Brigham and Women's Hospital , July 2009 , Phase 2 , Completed\,,,, Crohn's Disease , Certolizumab pegol , UCB Pharma ,20-Nov-07, Phase 3 , Completed\,,,, Pompe Disease , AT2220 , Amicus Therapeutics ,20-Nov-08, Phase 3 , Withdrawn\,,,, Alzheimer Disease , indomethacin , Radboud University ,20-May-00, Phase 2 , Terminated\,,,, Alzheimer's Disease , 250mg rilapladib , GlaxoSmithKline ,20-Oct-11, Phase 3 , Completed\,,,, Parkinson Disease , 18F-DTBZ AV-133 , Chang Gung Memorial Hospital ,20-Nov-11, Phase 2 , Completed\,,,, Parkinson's Disease , Repetitive transcranial magnetic stimulation (rTMS) , Beth Israel Deaconess Medical Center ,20-May-10, Phase 2 , Completed\,,,, Alzheimer's Disease , Dimebon , Medivation Inc., March 2009 , Phase 2 , Completed\,,,, Alzheimer Disease , Placebo Control , Transition Therapeutics Ireland Limited ,20-Dec-07, Phase 3 , Completed\,,,, Hodgkin's Disease , Methotrexate , Memorial Sloan Kettering Cancer Center ,19-Mar-94, Phase 2 , Completed\,,,, Cardiovascular Diseases , diet of fish and fruit , Menzies School of Health Research ,20-May-04, Phase 2 , Completed\,,,, Crohn's Disease , Probiotic - VSL#3 , University of Alberta ,20-Dec-03, Phase 3 , Completed\,,,, Parkinson's Disease , PYM50028 , Phytopharm ,20-Nov-10, Phase 3 , Completed\,,,, Crohn's Disease , AMG 827 , Amgen ,20-Dec-10, Phase 2 , Completed\,,,, Tourette's Syndrome , galantamine , Parkinson's Disease and Movement Disorders Center ,20-Sep-05, Phase 2 , Terminated\,,,, Crohn Disease , semapimod , Ferring Pharmaceuticals , June 2002 , Phase 4 , Terminated\,,,, Parkinson Disease , pramipexole , Boehringer Ingelheim ,20-May-06, Phase 2 , Terminated\,,,, Moderate to Severe Crohn's Disease , ADALIMUMAB , AbbVie , June 2014 , Phase 4 , Completed\,,,, Cardiovascular Diseases , polypill , Imperial College London , June 2010 , Phase 4 , Active, not recruiting\,,, Parkinson's Disease , TVP-1012 1mg , Takeda ,20-Jan-15, Phase 3 , Completed\,,,, Alzheimer Disease , Rivastigmine 5 cm^2 , Novartis Pharmaceuticals , June 2007 , Phase 2 , Completed\,,,, Alzheimer's Disease , GSK933776 , GlaxoSmithKline ,20-Mar-07, Phase 3 , Completed\,,,, Crohn Disease , Recombinant Human Interleukin-11 (rhIL-11) , Wyeth is now a wholly owned subsidiary of Pfizer ,20-Apr-02, Phase 1 , Completed\,,,, Chronic Kidney Disease , epoetin alfa , Johnson & Johnson Pharmaceutical Research & Development L.L.C., January 2006 , Phase 2 , Completed\,,,, Parkinson's Disease , Muscimol , National Institute of Neurological Disorders and Stroke (NINDS) , June 2009 , Phase 1 , Completed\,,,, Parkinson's Disease , Levodopa infusion , Helsinki University ,20-Apr-09, Phase 1 , Withdrawn\,,,, Graft vs Host Disease , Rituximab , Dana-Farber Cancer Institute ,20-Jan-04, Phase 4 , Completed\,,,, Acute Graft Versus Host Disease , Tocilizumab , Medical College of Wisconsin ,20-Aug-11, Phase 1 , Completed\,,,, Chronic Obstructive Pulmonary Disease , Roflumilast 500 , Spanish Research Center for Respiratory Diseases ,20-May-12, Phase 1 , Terminated\,,,, Parkinson's Disease , Dalfampridine , University of Miami , July 2012 , Phase 4 , Unknown status\,,,, Glycogen Storage Disease Type II , Myozyme , Genzyme, a Sanofi Company , Phase 1 , Completed\,,,, Crohn's Disease , adalimumab , Abbott ,20-Aug-06, Phase 2 , Completed\,,,, Alzheimer's Disease , placebo , AbbVie (prior sponsor, April 2003 , Phase 3 , Completed\,,,, Temporomandibular Disorders , Biofeedback-Based Cognitive Behavioral Treatment , Philipps University Marburg Medical Center ,20-Aug-08,, Phase 2 , Completed\,,, Parkinson's Disease , Cabergoline , Technische Universit\'e4t Dresden , February 2012 , Phase 2 , Completed\,,,, Early Parkinson's Disease , SPM 962 , Otsuka Pharmaceutical Co. Ltd,20-Feb-05, Phase 4 , Completed\,,,, Alzheimer's Disease , SK-PC-B70M , SK Chemicals Co. -  Clermont-Ferrand Ltd, September 2007 , Phase 2 , Completed\,,,, Gaucher Disease , Imigluc\'e9rase (drug) pharmacokinetics , University Hospital, April 2007 , Phase 2 , Completed\,,,, Cat-scratch Disease , prednison and azithromycin , Tel-Aviv Sourasky Medical Center -  and Alpha-lipoic Acid ,20-Dec-11, November 2012 , Phase 2 , Unknown status\,,, Alzheimer's Disease , Vitamin E - Vitamin C, National Institute on Aging (NIA) ,20-Apr-07, Phase 4 , Unknown status\,,,, Chronic Obstructive Pulmonary Disease , trospium chloride inhalation powder (TrIP) , Endo Pharmaceuticals , January 2006 , Phase 1 , Completed\,,,, Degenerative Disc Disease , YH14618 , Yuhan Corporation ,20-May-12, Phase 1 , Completed\,,,, Parkinson's Disease , N-acetylcysteine , University of Minnesota - Clinical and Translational Science Institute , July 2011 , Phase 1 , Completed\,,,, Crohn's Disease , abatacept , Bristol-Myers Squibb ,20-Dec-06, Phase 1 , Completed\,,,, Celiac Disease , Simvastatin , All India Institute of Medical Sciences, New Delhi , Phase 3 , Terminated\,,,, Parkinson's Disease , tDCS , Georgetown University ,20-Oct-13, April 2010 , Phase 2 , Completed\,,, Sickle Cell Disease , Hematopoietic Stem Cell Transplantation , Medical College of Wisconsin ,20-Aug-08, Phase 1 , Completed\,,,, Alzheimer's Disease , MT-4666 , Mitsubishi Tanabe Pharma Corporation ,20-Dec-14, Phase 2 , Active, not recruiting\,,, Intervertebral Disc Disease , Instrumented posterolateral arthrodesis , Red de Terapia Celular ,20-Jan-10, Phase 3 , Terminated\,,,, Alzheimer's Disease , LY2062430 , Eli Lilly and Company ,20-May-09, Phase 1 , Unknown status\,,,, Gastroesophageal Reflux Disease , Dexlansoprazole 30 mg , Takeda ,20-Mar-15, Phase 3 , Completed\,,,, Crohn's Disease , Epanova , Tillotts Pharma AG ,20-Jan-03, Phase 4 , Completed\,,,, Parkinson Disease , G-CSF , Buddhist Tzu Chi General Hospital , June 2010 , Phase 3 , Completed\,,,, Alzheimer's Disease , Placebo and ginkgo extract , Chinese University of Hong Kong ,20-Oct-04, Phase 2 , Terminated\,,,, Alzheimer's Disease , ABT-126 , AbbVie (prior sponsor Abbott), March 2012 , Phase 1 , Completed\,,,, Huntington's Disease , ACR16 , Teva Pharmaceutical Industries ,20-Apr-08, Phase 2 , Completed\,,,, Crohn's Disease , Ciprofloxacin , University of North Carolina - Chapel Hill, May 2008 , Phase 3 , Completed\,,,, Alzheimer's Disease , AC-3933 , Sunovion ,20-Feb-06, Phase 2 , Completed\,,,, Parkinson's Disease , Liatermin , Amgen ,20-Dec-03, Phase 2 , Completed\,,,, Crohn's Disease , 10% Metronidazole Ointment , S.L.A. Pharma AG ,20-May-05, Phase 1 , Completed\,,,, Movement Disorders , Eliprodil , National Institute of Neurological Disorders and Stroke (NINDS) ,19-Mar-99, Phase 3 , Completed\,,,, Alzheimer's Disease , Epigallocatechin-Gallate , Charite University - Berlin - Germany, October 2009 , Phase 2 , Completed\,,,, Dyskinesias , LY300164 , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Feb-00, Phase 2 , Completed\,,,, Parkinson Disease , Pramipexol Extended Release , Boehringer Ingelheim ,20-Apr-07, Phase 2 , Completed\,,,, Chronic Lymphoproliferative Diseases , GRN163L , Geron Corporation , July 2005 , Phase 3 , Completed\,,,, Positron-Emission Tomography , F-18 FEDAA1106 (BAY85-8101) , Bayer , June 2007 , Phase 1 , Completed\,,,, Relapsing Remitting Multiple Sclerosis , Fingolimod , Novartis Pharmaceuticals , June 2012 , Phase 1 , Completed\,,,, Graft Versus Host Disease , Visilizumab , H. Lee Moffitt Cancer Center and Research Institute ,20-Dec-07, Phase 4 , Completed\,,,, Alzheimer Disease , Acitretin , Johannes Gutenberg University Mainz ,20-Mar-10, Phase 2 , Terminated\,,,, Chagas Disease , Implantable Cardiac Monitor , Medtronic Cardiac Rhythm and Heart Failure , July 2013 , Phase 2 , Unknown status\,,,, Parkinson Disease , treatment with Nintendo wii. , Federal University of Bahia ,20-May-11, Phase 4 , Terminated\,,,, Eating Disorders , Promoting Eating Disorder Treatment among College Students , University of Michigan ,20-Jan-15, Phase 2 , Completed\,,,, Parkinson's Disease , SAM-e , New York University School of Medicine , July 2003 , Phase 1 , Completed\,,,, Parkinson's Disease , EMST - Active Treatment , University of Florida ,20-Jan-04, Phase 2 , Completed\,,,, Crohn Disease , Teduglutide (ALX-0600) , Shire ,20-Mar-04, Phase 1 , Completed\,,,, Huntington's Disease , Creatine Monohydrate , Massachusetts General Hospital ,20-May-09, Phase 2 , Completed\,,,, Crohn's Disease , Placebo , Pfizer ,20-Oct-11, Phase 2 , Completed\,,,, Parkinson Disease , N-0923 , National Institute of Neurological Disorders and Stroke (NINDS) ,19-May-99, Phase 2 , Completed\,,,, Huntington's Disease , Creatine monohydrate , Massachusetts General Hospital ,20-Apr-10, Phase 2 , Completed\,,,, Symptomatic Gastroesophageal Reflux Disease (sGERD) , rabeprazole sodium , Eisai Inc. ,20-Jan-09, Phase 2 , Completed\,,,, Crohn's Disease , Placebo matching with BMS-945429 , Alder Biopharmaceuticals Inc., June 2012 , Phase 3 , Completed\,,,, Peyronie's Disease , H-100 , Hybrid Medical , June 2013 , Phase 2 , Terminated\,,,, Crohn's Disease , RR110 (Tamibarotene) , R&R Inc. ,20-Dec-06, Phase 1 , Completed\,,,, Inflammatory Bowel Disease , Bacteriotherapy , David Suskind ,20-Dec-12, Phase 2 , Completed\,,,, Bipolar Disorder , Quetiapine , Mood Disorders Center of Ottawa , June 2004 , Phase 1 , Completed\,,,, Crohn's Disease , FDG PET CT , Rabin Medical Center ,20-Apr-08, Phase 3 , Completed\,,,, Non-alcoholic Fatty Liver Disease , Efamax , University of Nottingham ,20-Jan-09, Phase 4 , Unknown status\,,,, Heart Disease , Cardiac habilitation program , Oslo University Hospital ,20-Mar-13, Phase 2 , Completed\,,,, Dense Deposit Disease , CDX-1135 , Celldex Therapeutics ,20-Jan-13, Phase 0 , Unknown status\,,,, Crohn's Disease , Entocort , Perrigo Company ,20-Dec-11, Phase 1 , Terminated\,,,, Parkinson Disease , [18F]MPPF , Institute for Neurodegenerative Disorders ,20-Sep-11, Phase 3 , Completed\,,,, Huntington Disease , Ethyl-EPA (Miraxion\'99) , Amarin Neuroscience Ltd ,20-Sep-05, Phase 1 , Completed\,,,, Emotional Disorders , Unified treatment , Boston University ,20-Sep-05, Phase 3 , Completed\,,,, Chronic GVHD , Sirolimus + calcineurin inhibitor + prednisone , Medical College of Wisconsin ,20-Apr-10, Phase 3 , Completed\,,,, Sickle Cell Disease , laying-on-of-hands , MOA Health Science Foundation ,20-Mar-06, Phase 2 , Active, not recruiting\,,, Alzheimer's Disease , LY451395 , Eli Lilly and Company ,20-Nov-02, Phase 2 , Completed\,,,, Alzheimer's Disease , LY2062430 , Eli Lilly and Company ,20-May-09, Phase 2 , Completed\,,,, Graft Versus Host Disease , cyclosporine , Children's Oncology Group ,20-Apr-02, Phase 3 , Completed\,,,, Parkinson's Disease , Tai Chi , Oregon Research Institute ,20-Oct-08, Phase 3 , Completed\,,,, Degenerative Disc Disease , XL TDR , NuVasive , July 2009 , Phase 2 , Completed\,,,, Crohn Disease , infliximab , Centocor,20-May-14, Phase 3 , Completed\,,,, Crohn's Disease , MT-1303 , Mitsubishi Tanabe Pharma Corporation , February 2003 , Phase 3 , Completed\,,,, Parkinson Disease , SR57667B , Sanofi ,20-Jan-04, Phase 1 , Completed\,,,, Alzheimer's Disease , CX516 (Ampalex) , National Institute of Neurological Disorders and Stroke (NINDS) ,19-Dec-96, Phase 2 , Completed\,,,, Parkinson's Disease , KW-6002 , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Oct-00, Phase 2 , Completed\,,,, Alzheimer Disease , Leuprolide acetate , Voyager Pharmaceutical Corporation ,20-Dec-03, Phase 2 , Completed\,,,, Advanced Parkinson's Disease , ABT-SLV187 , AbbVie ,20-Sep-15, Phase 2 , Completed\,,,, Parkinson's Disease , Istradefylline (KW-6002) , Kyowa Kirin Pharmaceutical Development Inc.,20-Mar-10, Phase 3 , Enrolling by invitation\,,,, Chronic Obstructive Pulmonary Disease (COPD) , Opioid (morphine sulphate) in low dose , Nova Scotia Health Authority , July 2004 , Phase 3 , Completed\,,,, Chronic Kidney Disease , SBR759 , Novartis Pharmaceuticals ,20-Feb-07, Phase 2 , Completed\,,,, Graft Versus Host Disease , Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue. , Andalusian Initiative for Advanced Therapies - Fundaci\'f3n P\'fablica Andaluza Progreso y Salud , June 2010 , Phase 1 , Completed\,,,, Idiopathic Parkinson's Disease , Rotigotine , UCB Korea Co.,20-May-13, Phase 1 , Completed\,,,, Parkinson's Disease , Elastic abdominal binder , Medical University Innsbruck , April 2012 , Phase 4 , Completed\,,,, Vaso-occlusive Crisis , Saline , Mast Therapeutics, May 2013 , Phase 2 , Completed\,,,, End Stage Renal Disease , eravacycline , Tetraphase Pharmaceuticals, July 2008 ,, Phase 3 , Completed\,,, Crohn's Disease , Naltrexone , Penn State University , December 2013 ,, Phase 1 , Completed\,,, Alzheimer's Disease , 123-I MNI-340 , Institute for Neurodegenerative Disorders ,20-Apr-08, Phase 2 , Completed\,,,, Parkinson's Disease , Tyrosine , New York Institute of Technology ,20-Sep-12, Phase 1 , Terminated\,,,, Alzheimer Disease , galantamine , Johnson & Johnson Pharmaceutical Research & Development, October 2008 , Phase 1 , Completed\,,,, Peripheral Arterial Disease , SilverHawk\'99 LS-C, TurboHawk\'99 LS-C,May 2 2002, Phase 4 , Completed\,,,, Crohn's Disease , MT-1303 , Mitsubishi Tanabe Pharma Corporation ,20-Aug-15, Phase 2 , Completed\,,,, Post-traumatic Stress Disorder , Cognitive behavioral couples therapy for post-traumatic stress disorder (CBCT for PTSD) , Ryerson University ,20-Aug-08, Phase 2 , Active, not recruiting\,,, Cardiovascular Disease , AUC monitored withdrawal of MMF or CNI , Leiden University Medical Center ,20-Dec-05, Phase 2 , Completed\,,,, Alzheimer's Disease , Donepezil HCL , Eisai Korea Inc. ,20-Feb-14, Phase 4 , Completed\,,,, Celiac Disease , 4 dose levels of ALV003 , Alvine Pharmaceuticals Inc. ,20-Feb-08, Phase 4 , Completed\,,,, Oral Chronic Graft vs Host Disease , Clobetasol Oral Rinse , National Cancer Institute (NCI) ,20-Jan-12, Phase 1 , Completed\,,,, Parkinson's Disease , physical therapy , Katholieke Universiteit Leuven , June 2011 , Phase 2 , Active, not recruiting\,,, Peripheral Vascular Diseases , Vasovist (BAY86-5283, MS-325) , Bayer , Phase 3 , Completed\,,,, Panic Disorders , VENLAFAXINE , Wyeth is now a wholly owned subsidiary of Pfizer ,20-Jan-05, February 2006 , Phase 3 , Completed\,,, Alzheimer's Disease , MK-0249 7.5 mg , Merck Sharp & Dohme Corp. ,20-Apr-09, Phase 3 , Completed\,,,, Alzheimer's Disease , Bapineuzumab , JANSSEN Alzheimer Immunotherapy Research & Development, LLC , Phase 1 , Terminated\,,,, Alzheimer's Disease , TC-5619 , Targacept Inc. ,20-Sep-10, July 2009 , Phase 3 , Terminated\,,, Von Hippel-Lindau Disease , Vorinostat , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Mar-14, Phase 1 , Completed\,,,, Crohn's Disease , adalimumab , Abbott ,20-Mar-07, Phase 1 , Enrolling by invitation\,,,, Idiopathic Parkinson's Disease , Safinamide, MAO-B inhibitor  Newron ,20-Mar-09, Phase 2 , Completed\,,,, Parkinson's Disease , EMST , VA Office of Research and Development , October 2009 , Phase 3 , Terminated\,,,, Crohn Disease , Sargramostim (Leukine) , Genzyme  a Sanofi Company ,20-Mar-09, Phase 2 , Completed\,,,, Alzheimer's Disease , florbetapir F 18 , Avid Radiopharmaceuticals , July 2004 , Phase 3 , Terminated\,,,, Parkinson Disease , Kinetra and Soletra (neurostimulator  Medtronic) , German Parkinson Study Group (GPS) ,20-Aug-07, Phase 2 , Completed\,,,, Parkinson's Disease , BIIB014 , Biogen , July 2006 , Phase 4 , Unknown status\,,,, Crohn's Disease , Adalimumab , AbbVie ,20-Aug-14, Phase 2 , Completed\,,,, Infantile Canavan Disease , GTA: Glyceryltriacetate , Sheba Medical Center ,20-Jan-06, Phase 3 , Enrolling by invitation\,,,, Crohn Disease , Placebo , Boehringer Ingelheim ,20-Oct-01, Phase 1 , Unknown status\,,,, Crohn's Disease , Methoxsalen +ECP , Mallinckrodt ,20-Dec-04, Phase 2 , Terminated\,,,, Celiac Disease , ALV003 , Alvine Pharmaceuticals Inc. ,20-Mar-08, Phase 2 , Completed\,,,, Parkinson's Disease , 18F-FDG , Chang Gung Memorial Hospital ,20-Aug-10, Phase 1 , Completed\,,,, Crohns Disease , glatiramer acetate , Tel-Aviv Sourasky Medical Center ,20-Sep-08, Phase 2 , Completed\,,,, Parkinson Disease , Neopulse Magnetic Stimulator , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Jan-02, Phase 2 , Unknown status\,,,, Hepatic Veno-Occlusive Disease , Defibrotide , European Group for Blood and Marrow Transplantation ,20-Dec-05, Phase 2 , Completed\,,,, CROHN'S DISEASE , Immune Ablation and Hematopoietic Stem Cell Support , Richard Burt, MD , Phase 2 , Completed\,,,, Alzheimer's Disease , Tryptophan , Queen's University ,20-Apr-01, April 2001 , Phase 1 , Terminated\,,, Fabry Disease , migalastat hydrochloride , Amicus Therapeutics ,20-Dec-10, Phase 4 , Completed\,,,, Graft vs Host Disease , Decidual Stromal Cells thawed in plasma , Karolinska Institutet ,20-Jan-11, Phase 3 , Completed\,,,, Parkinson Disease , [123I]CLINDE , Institute for Neurodegenerative Disorders ,20-Jan-08, Phase 1 , Unknown status\,,,, Crohn Disease , Tacrolimus , University of Aberdeen ,Nov 2 2010, Phase 1 , Terminated\,,,, Alzheimer's Disease , T3D-959 , T3D Therapeutics,20-Mar-09, Phase 2 , Completed\,,,, Parkinson's Disease , Safinamide , Newron , July 2015 , Phase 1 , Active, not recruiting\,,, High Risk HLA-A2+ Melanoma , Melanoma vaccine modified to express HLA A2/4-1BB ligand , Hadassah Medical Organization , June 2013 , Phase 3 , Completed\,,,, Alzheimer Disease , Florbetaben (BAY94-9172) , Piramal Imaging SA ,20-Aug-08, Phase 2 , Unknown status\,,,, Sickle Cell Disease , aspirin , University of Rochester ,20-Mar-05, Phase 2 , Completed\,,,, Crohn's Disease , Placebo , Abbott ,20-Nov-07, Phase 1 , Completed\,,,, Parkinson's Disease , Far Infrared Radiation (5um to 20 um wavelgnth), GAAD Medical Research Institute Inc. , May 2008 , Phase 1 , Terminated\,,,, Crohn's Disease , risedronate , University of Alberta ,5-Oct, Unknown status\,,,,, Gait Disorders, Neurologic , droxidopa , Chelsea Therapeutics ,2010, Phase 4 , Completed\,,, Crohn's Disease , RPC1063 , Celgene ,20-Sep-15, April 2012 , Phase 1 , Withdrawn\,,, Inflammatory Bowel Disease , Curcumin , Seattle Children's Hospital ,20-May-09, Phase 2 , Active, not recruiting\,,, Parkinson's Disease , [F18]-FDDNP , Fundacion Clinic per a la Recerca Biom\'e9dica ,20-Mar-10, Phase 1 , Completed\,,,, Panic Disorder , Clonazepam , Massachusetts General Hospital ,19-Mar-99, Phase 0 , Completed\,,,, Crohn's Disease , STA-5326 mesylate , Synta Pharmaceuticals Corp. ,20-Nov-05, Phase 2 , Completed\,,,, Fabry Disease , AT1001 , Amicus Therapeutics ,20-Sep-07, Phase 2 , Completed\,,,, Crohn's Disease , GLPG0634 , Galapagos NV Inc.,20-Feb-14, Phase 2 , Completed\,,,, Alzheimer's Disease , PRX-03140 , Epix Pharmaceuticals,, Phase 2 , Completed\,,,, Alzheimer's Disease , Bexarotene , The Cleveland Clinic ,20-Feb-13, April 2008 , Phase 2 , Terminated\,,, Interstitial Lung Disease , bosentan , Actelion , July 2004 , Phase 2 , Completed\,,,, Parkinson Disease , Vitamin D3 , Memorial Medical Center ,20-Sep-09, Phase 2 , Completed\,,,, Parkinson's Disease , ROTIGOTINE , Luye Pharma Group Ltd. ,20-May-16, Phase 2 , Completed\,,,, Crohn Disease , OPC-6535(Tetomilast) , Otsuka Pharmaceutical Co.,, Phase 1 , Completed\,,,, Inflammatory Bowel Disease 11 , Prednisone , University of British Columbia ,20-Oct-13, May 2006 , Phase 2 , Terminated\,,, Celiac Disease , CCX282-B , ChemoCentryx ,20-Oct-07, Phase 4 , Completed\,,,, Chronic Kidney Disease , FG-4592 , FibroGen ,20-May-12, Phase 2 , Completed\,,,, Chronic Obstructive Pulmonary Disease , Cyclosporine , University of Pittsburgh ,20-Sep-09, Phase 2 , Enrolling by invitation\,,,, Graft-Versus-Host Disease , Panobinostat (LBH589) , H. Lee Moffitt Cancer Center and Research Institute -  University of Saskatchewan ,20-Apr-10, Phase 1 , Active, not recruiting\,,, Parkinson Disease , Exercise, Education ,, Phase 1 , Active, not recruiting\,,, Parkinson's Disease , 18F- DTBZ , Chang Gung Memorial Hospital ,20-Mar-12, September 2005 , Phase 1 , Completed\,,, Life Threatening Diseases , Imatinib mesylate , Novartis Pharmaceuticals ,20-Feb-01, Phase 2 , Completed\,,,, Adult Polyglucosan Body Disease , Triheptanoin , Baylor Research Institute , June 2009 , Phase 2 , Completed\,,,, Stem Cell Leukemia of Unclear Lineage , extracorporeal photopheresis , University of Kansas  Inc. , June 2010 , Phase 2 , Completed\,,,, Alzheimer's Disease , PRX-03140 , Epix Pharmaceuticals  Education,, Phase 0 , Unknown status\,,,, Parkinson Disease , Laser light (U-Step Walking Stabilizer with laser light) , Parkinson's Disease Research, May 2008 , Phase 2 , Terminated\,,,, Alzheimer's Disease , GSK239512 , GlaxoSmithKline ,20-Feb-08, and Clinical Center, Philadelphia , June 2003 , Phase 3 , Completed\, Graft Versus Host Disease , daclizumab , Dana-Farber Cancer Institute ,20-Oct-02, Phase 1 , Completed\,,,, Alzheimer's Disease , Placebo , AbbVie (prior sponsor, Abbott) , Phase 3 , Unknown status\,,,, Crohn's Disease , mobilization of stem cells to prepare for Leukapheresis , Nationwide Children's Hospital ,20-Apr-13, October 2009 , Phase 2 , Completed\,,, Crohn's Disease , G-CSF , National Institute of Allergy and Infectious Diseases (NIAID) ,20-Oct-01, Phase 2 , Terminated\,,,, Alzheimer's Disease , ABT-957 , AbbVie ,20-Sep-14, Phase 1 , Completed\,,,, Alzheimer's Disease , ABT-354 , AbbVie , July 2013 , Phase 1 , Terminated\,,,, Glycogen Storage Disease Type II , Myozyme , Genzyme, a Sanofi Company , Phase 1 , Completed\,,,, Crohn's Disease , CT-P13 , Celltrion , July 2014 , June 2005 , Phase 2 , Completed\,,, Parkinson Disease , active tDCS , National Cheng-Kung University Hospital ,20-Aug-15, Phase 3 , Active, not recruiting\,,, Crohn's Disease , Cimzia , Milton S. Hershey Medical Center ,20-Feb-13, Phase 1 , Active, not recruiting\,,, Parkinson's Disease , AAV-hAADC-2 , Genzyme, a Sanofi Company , Phase 4 , Terminated\,,,, Alzheimer's Disease , PF-04360365 , Pfizer ,20-Mar-10, November 2004 , Phase 1 , Completed\,,, Renal Disease , 200 mg Ceftaroline fosamil , AstraZeneca ,20-Feb-13, Phase 1 , Completed\,,,, Fabry Disease , Agalsidase beta , Genzyme, a Sanofi Company , Phase 1 , Completed\,,,, Cardiovascular Diseases , Minimal intervention , University of Iowa ,20-Mar-08, July 2005 , Phase 4 , Completed\,,, Crohn Disease , Mesenchymal stromal cells (MSC) for infusion , R.P.Herrmann ,20-Jan-10, Phase 3 , Completed\,,,, Graft-Versus-Host Disease , Pentostatin , Ohio State University Comprehensive Cancer Center , July 2003 , Phase 2 , Completed\,,,, Anemia, Sickle Cell , Magnesium Pidolate, Hydroxyurea , Phase 2 , Completed\,,,, Kidney Disease, Chronic , Methoxy polyethylene glycol-epoetin beta , Hoffmann-La Roche , St. Jude Children's Research Hospital , November 2004 , Phase 1 , Completed\,, Chronic Obstructive Pulmonary Disease , Metformin , St George's, University of London , September 2010 , Phase 2 , Completed\,,, Parkinson's Disease , carbidopa and levodopa , IMPAX Laboratories, Inc. , January 2011 , Phase 4 , Completed\,,, Crohn Disease , Infliximab , Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives ,20-Dec-05, November 2015 , Phase 2 , Active, not recruiting\,, Mild-to-moderate Alzheimer's Disease , SB-742457 15mg , GlaxoSmithKline , July 2008 , Phase 3 , Completed\,,,, Parkinson Disease , Phoressor II (IOMED) , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Mar-03, Phase 2 , Completed\,,,, Diabetes Mellitus Type 2, Kidney Disease, Chronic , Aleglitazar , Phase 2 , Completed\,,,, Parkinson's Disease , Safinamide , Newron , June 2005 , Hoffmann-La Roche , December 2013 , Phase 3 , Withdrawn\,, Mild Cognitive Impairment Due to Alzheimer's Disease , Pioglitazone , Takeda ,20-Aug-13, Phase 3 , Completed\,,,, Idiopathic Parkinson's Disease , Safinamide , Newron ,20-Dec-04, Phase 3 , Active, not recruiting\,,, Chronic Kidney Disease , Placebo , Mitsubishi Tanabe Pharma Corporation , July 2007 , Phase 3 , Completed\,,,, Smoking Cessation , High intensity disease management , University of Kansas Medical Center , June 2009 , Phase 3 , Completed\,,,, Idiopathic Parkinson's Disease , Istradefylline 40 mg , Kyowa Hakko Kirin Pharma, Inc. , Phase 3 , Completed\,,,, Peripheral Arterial Disease , dark chocolate with crossover to milk chocolate , University of Roma La Sapienza ,20-Oct-10, October 2013 , Phase 3 , Active, not recruiting\,, Alzheimer Disease , Placebo , Wyeth is now a wholly owned subsidiary of Pfizer ,20-Aug-08, Phase 1 , Completed\,,,, Impulse Control Disorder , Naltrexone , University of Pennsylvania ,20-Nov-09, Phase 1 , Terminated\,,,, Coronary Artery Disease , E5555 50 mg , Eisai Co., Ltd. , Phase 4 , Completed\,,,, Alzheimers Disease , 123-I MNI-187 Injection and Imaging Procedures , Institute for Neurodegenerative Disorders ,20-Apr-07, October 2007 , Phase 2 , Completed\,,, Alzheimer's Disease , SRA-333 , Wyeth is now a wholly owned subsidiary of Pfizer ,20-Feb-05, Phase 1 , Completed\,,,, Crohn's Disease , GSK1605786A , GlaxoSmithKline ,20-May-11, Phase 2 , Completed\,,,, Parkinson Disease , Magstim Rapid Magnetic Stimulator , National Institute of Neurological Disorders and Stroke (NINDS) , June 2003 , Phase 3 , Terminated\,,,, Parkinson's Disease , TVP-1012 , Takeda ,20-Feb-15, Phase 1 , Completed\,,,, Parkinson Disease , B-CIT and SPECT imaging , Institute for Neurodegenerative Disorders ,20-Nov-06, Phase 3 , Completed\,,,, Alzheimer's Disease , PF-04360365 1 mg/kg , Pfizer ,20-Aug-08, Phase 2 , Completed\,,,, Graft Versus Host Disease , Ibrutinib , Pharmacyclics LLC. , July 2014 , Phase 1 , Completed\,,,, Idiopathic Parkinson's Disease , CERE-120: Adeno-Associated Virus Delivery of Neurturin , Ceregene ,20-Sep-09, Phase 1 , Active, not recruiting\,,, Graft Versus Host Disease , beclomethasone dipropionate , Memorial Sloan Kettering Cancer Center ,20-Apr-02, Phase 1 , Active, not recruiting\,,, Congenital Heart Disease , Motavizumab , MedImmune LLC ,20-Oct-05, Phase 3 , Completed\,,,, Treatment of Dry Eye Disease , Restasis, Refresh Plus , Innovative Medical , Phase 2 , Completed\,,,, Crohn's Disease , Adalimumab , AbbVie ,20-Dec-13, November 2007 , Phase 4 , Completed\,,, Crohn's Disease , Infliximab , Merck Sharp & Dohme Corp. ,20-Nov-03, Phase 2 , Completed\,,,, Inflammatory Bowel Disease , Low dose naltrexone , Santa Barbara Cottage Hospital ,20-Mar-13, Phase 3 , Terminated\,,,, Sickle Cell Disease , Hydroxyurea , Ann & Robert H Lurie Children's Hospital of Chicago , July 2006 , Phase 2 , Withdrawn\,,,, Huntington's Disease , coenzyme Q10 , Massachusetts General Hospital ,20-Mar-08, Phase 1 , Terminated\,,,, Paget's Disease of Bone , alendronate , Merck Sharp & Dohme Corp. ,20-Oct-01, Phase 3 , Terminated\,,,, Parkinson's Disease , Multidisciplinary Care , Radboud University ,20-Aug-07, Phase 3 , Completed\,,,, Alzheimer Disease , galantamine hydrobromide , Johnson & Johnson Pharmaceutical Research & Development, L.L.C. , Phase 3 , Completed\,,,, Parkinson Disease , CoQ10 , University of Rochester ,20-Jan-04, July 1997 , Phase 3 , Completed\,,, Parkinson's Disease , apomorphine hydrochloride , Kyowa Hakko Kirin Company, Limited , Phase 2 , Completed\,,,, Crohn's Disease , E6011 , Eisai Inc. ,20-Dec-14, November 2007 , Phase 2 , Completed\,,, Parkinson's Disease , Rasagiline , University of Zurich ,20-Sep-11, Phase 1 , Withdrawn\,,,, Celiac Disease , AGY , Igy Inc. ,20-May-14, Phase 4 , Terminated\,,,, Parkinson's Disease , BF2.649 (pitolisant) , Bioprojet ,20-Dec-09, Phase 1 , Completed\,,,, Parkinson Disease , Liraglutide , Cedars-Sinai Medical Center ,20-Sep-16, Phase 3 , Completed\,,,, Huntington's Disease , delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) , Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal ,20-Sep-11, Phase 2 , Active, not recruiting\,,, Crohn\'b4s Disease , Pentasa , Ferring Pharmaceuticals ,20-Apr-09, Phase 2 , Completed\,,,, Parkinson Disease , sumanirole , Pfizer ,20-Apr-03, Phase 3 , Terminated\,,,, Parkinson Disease , pramipexole immediate release tablet , Boehringer Ingelheim ,20-Aug-10, Phase 3 , Completed\,,,, Parkinson Disease , bee venom , Assistance Publique - H\'f4pitaux de Paris ,20-Mar-11, Phase 3 , Completed\,,,, Alzheimer's Disease , PPI-1019 (APAN) , PRAECIS Pharmaceuticals Inc. ,20-May-03, Phase 2 , Completed\,,,, Coronary Artery Disease , Clopidogrel , Takeshi Morimoto ,20-Feb-10, Phase 1 , Completed\,,,, Kidney Disease , Zemplar Capsule , Abbott ,20-Aug-04, Phase 4 , Completed\,,,, Autoimmune Disease , Enteric-coated Mycophenolate Sodium , Novartis Pharmaceuticals , June 2006 , Phase 3 , Completed\,,,, Parkinson Disease , sumanirole , Pfizer ,20-Dec-01, Phase 3 , Completed\,,,, Inflammatory Bowel Disease , Monofer (iron isomaltoside 1000) , Pharmacosmos A/S ,20-Feb-12, Phase 3 , Completed\,,,, Alzheimer's Disease , AC-1204 , Accera, Inc. , Phase 1 , Completed\,,,, Chronic Kidney Disease , Placebo , Mitsubishi Tanabe Pharma Corporation , July 2007 , March 2013 , Phase 2 , Active, not recruiting\,, Crohn's Disease , AMG 181 , Amgen ,20-Dec-12, Phase 3 , Completed\,,,, Jansky-Bielschowsky Disease , BMN 190 , BioMarin Pharmaceutical ,20-Sep-13, Phase 2 , Active, not recruiting\,,, Huntington's Disease , PF-02545920 , Pfizer ,20-Sep-13, Phase 1 , Completed\,,,, Chronic Obstructive Pulmonary Disease (COPD) , Bone marrow harvesting , UPECLIN HC FM Botucatu Unesp ,20-Apr-15, Phase 2 , Completed\,,,, Alzheimer's Disease , Bryostatin for Injection , Blanchette Rockefeller Neurosciences Insitute ,20-Apr-08, Phase 1 , Enrolling by invitation\,,,, Adult-Onset Still's Disease , anakinra , Helsinki University ,20-Dec-05, Phase 2 , Unknown status\,,,, Non-Alcoholic Fatty Liver Disease , OMACOR , University Hospital Southampton NHS Foundation Trust ,20-Nov-09, Phase 2 , Unknown status\,,,, Rheumatoid Arthritis , infliximab , Merck Sharp & Dohme Corp. , June 2007 , Phase 2 , Active, not recruiting\,,, Alzheimer's Disease , CAD106 , Novartis Pharmaceuticals , June 2005 , Phase 3 , Terminated\,,,, Crohn's Disease , ALX-0600 , Shire ,20-Oct-03, Phase 1 , Completed\,,,, Graft Versus Host Disease , Bortezomib , University of California, Davis , Phase 2 , Completed\,,,, Parkinson Disease , N-acetylcysteine , Weill Medical College of Cornell University ,20-Jan-12, July 2012 , Phase 1 , Active, not recruiting\,, Alzheimer's Disease , DHA (Docosahexaenoic Acid) , Alzheimer's Disease Cooperative Study (ADCS) ,20-Feb-07, Phase 1 , Completed\,,,, Parkinson's Disease , MK0657 , Merck Sharp & Dohme Corp. ,20-May-07, Phase 3 , Completed\,,,, Parkinson Disease , Preladenant 2 mg tablet , Merck Sharp & Dohme Corp. , July 2010 , Phase 1 , Completed\,,,, Hodgkin's Disease , MDX-060 , Bristol-Myers Squibb ,20-Nov-05, Phase 3 , Completed\,,,, Granulomatous Disease, Chronic, X-linked, Variant , Phase 2 , Completed\,,,, Crohn's Disease , Cx601 , TiGenix S.A.U. , July 2012 , pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion , Great Ormond Street Hospital for Children NHS Foundation Trust , November 2011 , Phase 1 , Withdrawn\, Immunogenicity and Adverse Drug Effect of Vaccines Influenza , Seasonal influenza vaccine (AdimFlu-S) , National Cheng-Kung University Hospital ,20-Oct-13, Phase 3 , Active, not recruiting\,,, Alzheimer's Disease , T-817MA-H , Toyama Chemical Co., Ltd. , Phase 4 , Unknown status\,,,, Diagnostic Imaging , BAY1006578 , Piramal Imaging SA , June 2010 , March 2014 , Phase 2 , Active, not recruiting\,, Chronic Kidney Disease , Valsartan , Chinese PLA General Hospital ,20-Nov-14, Phase 1 , Completed\,,,, Congenital Heart Disease , Vasovist , Guy's Hospital ,20-Mar-07, Phase 4 , Unknown status\,,,, Crohn's Disease , Trichuris suis ova , Coronado Biosciences, Inc. , Phase 4 , Unknown status\,,,, Chronic Obstructive Pulmonary Disease (COPD) , NVA237 100 \'b5g , Novartis ,20-Aug-07, November 2011 , Phase 1 , Completed\,,, Chronic Kidney Disease Stage 3 and 4 , Zemplar (paricalcitol) Capsules , AbbVie (prior sponsor, Abbott) , Phase 2 , Completed\,,,, Parkinson's Disease Psychosis , pimavanserin tartrate (ACP-103) , ACADIA Pharmaceuticals Inc. , July 2007 , February 2010 , Phase 3 , Completed\,,, Alzheimer's Disease , escitalopram , Konkuk University Medical Center ,20-Nov-11, Phase 3 , Active, not recruiting\,,, Alzheimer Disease , bapineuzumab , Pfizer ,20-Jan-08, Phase 4 , Completed\,,,, Sickle Cell Disease , Arginine , Emory University ,20-May-15, Phase 3 , Terminated\,,,, Parkinson's Disease , blood draw , Howard Gendelman, MD , Phase 1 , Enrolling by invitation\,,,, Alzheimer's Disease , Placebo , Hoffmann-La Roche ,20-May-09, September 2013 , Phase 1 , Completed\,,, Alzheimer Disease , galantamine hydrobromide , Johnson & Johnson Pharmaceutical Research & Development, L.L.C. , Phase 2 , Completed\,,,, Lymphoproliferative Disorder , rituximab , Children's Oncology Group ,20-Apr-04, March 2001 , Phase 3 , Completed\,,, Vascular Disease , Verbal and written information , Mid Western Regional Hospital, Ireland , Phase 2 , Active, not recruiting\,,, Osgood-Schlatter Disease , Dextrose Injection , Universidad Nacional de Rosario ,20-Jan-06, May 2013 , Phase 2 , Completed\,,, Alzheimer's Disease , Aricept (donepezil SR 23 mg) , Eisai Inc. , June 2007 , Phase 1 , Completed\,,,, Alzheimer Disease , galantamine hydrobromide , Johnson & Johnson Pharmaceutical Research & Development, L.L.C. , Phase 3 , Completed\,,,, Alzheimer Disease , galantamine hydrobromide , Johnson & Johnson Pharmaceutical Research & Development, L.L.C. , November 10,2005, Phase 3 , Completed\,, Alzheimer's Disease , ABT-089 , Abbott ,20-Nov-07, February 1997 , Phase 3 , Completed\,,, Alzheimer Disease , bapineuzumab , Pfizer , June 2008 , Phase 2 , Terminated\,,,, Advanced Parkinson's Disease , Rotigotine , UCB BIOSCIENCES GmbH ,20-Oct-12, Phase 3 , Terminated\,,,, Chronic Obstructive Pulmonary Disease , MEDI8968 SC for 12 months , MedImmune LLC ,20-Nov-11, Phase 3 , Completed\,,,, Parkinson's Disease , Preladenant , Merck Sharp & Dohme Corp. ,20-Feb-11, Phase 2 , Completed\,,,, Alzheimer Disease , Estrogen , National Institute on Aging (NIA) ,29-Oct, Phase 2 , Completed\,,,, Alzheimer's Disease , MRI , Merck Sharp & Dohme Corp. ,20-Sep-08,1999, Phase 3 , Completed\,,, Alzheimer Disease , Atorvastatin calcium , Institute for the Study of Aging (ISOA) ,20-Oct-00, Phase 1 , Completed\,,,, Alzheimer's Disease , Rosiglitazone (Extended Release) , GlaxoSmithKline ,20-Apr-08, Phase 2 , Completed\,,,, Parkinson Disease , SR57667B , Sanofi , July 2003 , Phase 1 , Completed\,,,, Relapsed Multiple Myeloma , Carfilzomib , Onyx Therapeutics, Inc. , Phase 2 , Completed\,,,, Parkinson's Disease , Physical therapy aimed to move safely , Radboud University ,20-Sep-08, January 2014 , Phase 1 , Active, not recruiting\,, Crohn's Disease , Alequel , Hadassah Medical Organization ,20-Jan-08, Phase 3 , Completed\,,,, Coronary Artery Disease , Bradykinin , Vanderbilt University ,20-Dec-03, Phase 1 , Completed\,,,, Anxiety Disorders , Single Diagnosis Treatment Protocol , Boston University ,20-Dec-10, Phase 1 , Enrolling by invitation\,,,, Parkinson's Disease , PET/CT , Asan Medical Center ,20-Nov-06, Phase 3 , Active, not recruiting\,,, Crohn's Disease , PF-04236921 SC injection , Pfizer ,20-Feb-11, Phase 3 , Completed\,,,, Alzheimer's Disease , PF-03654746 , Pfizer ,20-Dec-09, Phase 2 , Completed\,,,, Parkinson Disease , Isradipine CR 5mg , Northwestern University , July 2009 , Phase 1 , Terminated\,,,, Parkinson's Disease , Memantine , Baylor College of Medicine ,20-Apr-06, Phase 2 , Completed\,,,, Parkinson's Disease , Light box (Litebook company) , McGill University Health Center ,20-Jan-11, Phase 4 , Completed\,,,, Peripheral Arterial Disease , Dotarem , Guerbet ,20-Oct-09, Phase 0 , Completed\,,,, Chronic Granulomatous Disease , Gene Therapy Method for CGD , National Institute of Allergy and Infectious Diseases (NIAID) , June 1995 , Phase 4 , Completed\,,,, Chronic Kidney Disease , Tolvaptan (OPC-41061) , Otsuka Pharmaceutical Development & Commercialization, Inc. , Phase 1 , Completed\,,,, Dry Eye Disease , P-321 Ophthalmic Solution , Parion Sciences , July 2014 , May 2014 , Phase 3 , Active, not recruiting\,, Thyroid Diseases , chinese herbs-I , Tianjin Medical University Cancer Institute and Hospital , June 2012 , Phase 1 , Completed\,,,, Crohn's Disease , cannabidiol , Meir Medical Center ,20-Jan-10, Phase 1 , Unknown status\,,,, Parkinson's Disease , Rotigotine , UCB Pharma ,20-Dec-04, Phase 1 , Completed\,,,, Crohn Disease , infliximab or placebo , Centocor, Inc. , Phase 3 , Completed\,,,, Hodgkin's Disease , lenograstim , WiSP Wissenschaftlicher Service Pharma GmbH ,20-May-03, June 2000 , Phase 3 , Completed\,,, Graft vs Host Disease , Extracorporeal Photopheresis , National Institute of Allergy and Infectious Diseases (NIAID) ,20-Nov-02, Phase 2 , Completed\,,,, Chagas Disease , Benznidazole , Drugs for Neglected Diseases ,20-Apr-11, Phase 2 , Completed\,,,, Parkinson Disease , Intravenous Levodopa , National Institute of Neurological Disorders and Stroke (NINDS) ,20-Aug-04, Phase 4 , Unknown status\,,,, Chronic Kidney Disease , Intravenous injection , Royan Institute ,20-Apr-14, Phase 2 , Completed\,,,, Parkinson's Disease Psychosis , Pimavanserin tartrate (ACP-103) , ACADIA Pharmaceuticals Inc. , June 2007 , Phase 1 , Completed\,,,, Gaucher Disease, Type 1 , GA-GCB (velaglucerase alfa) , Shire , Phase 3 , Completed\,,,, Crohn's Disease , Azithromycin + Metronidazole , Prof. Arie Levine ,20-Oct-12, July 2007 , Phase 2 , Completed\,,, Lesch-Nyhan Disease , Ecopipam , Psyadon Pharma ,20-Dec-12, Phase 4 , Completed\,,,, Celiac Disease , Gluten challenge. , Oslo University Hospital ,20-Sep-06, Phase 3 , Terminated\,,,, Alzheimer's Disease , PF-04447943 , Pfizer ,20-Oct-09, Phase 2 , Completed\,,,, Lyme Disease , Antibiotics , National Institute of Allergy and Infectious Diseases (NIAID) ,2-Nov, Phase 1 , Completed\,,,, Coronary Disease , Evidence summaries endorsed by local opinion leaders , University of Alberta ,20-Mar-05,1999, Phase 3 , Completed\,,, Pompe Disease , Albuterol , Duke University , June 2012 , Phase 4 , Completed\,,,, Parkinson's Disease , carbidopa, levodopa, entacapone , Phase 1 , Completed\,,,, Alzheimer Disease , Naproxen , Douglas Mental Health University Institute ,20-Aug-12, Novartis , July 2005 , Phase 4 , Completed\,, Hepatic Veno-Occlusive Disease , Freeze-dried Concentrated Human Antithrombin \uc0\u8546  500 IU , Seoul National University Hospital , June 2013 , Phase 2 , Active, not recruiting\,,, Parkinson's Disease , SPM 962 , Otsuka Pharmaceutical Co., Ltd. , Phase 2 , Active, not recruiting\,,, Idiopathic Parkinson's Disease , piribedil , Desitin Arzneimittel GmbH ,20-Jan-10, January 2005 , Phase 2 , Completed\,,, Parkinson Disease , Ropinirole prolonged release/extended release(PR/XR) , GlaxoSmithKline ,20-Apr-07, Phase 3 , Completed\,,,, Gaucher Disease , Taliglucerase alfa , Protalix ,20-Sep-11, Phase 2 , Completed\,,,, Parkinson Disease , Ropinirole , GlaxoSmithKline , June 2003 , Phase 3 , Completed\,,,, Peripheral Arterial Disease , Flaxseed , Dr. Grant Pierce ,20-Oct-08, Phase 3 , Completed\,,,, Parkinson Disease , Traditional Chinese Medicinal Mixture (composed of Roucongrong and adjuvant) , Fudan University ,20-Nov-08, Phase 2 , Active, not recruiting\,,, Alzheimer Disease , Cerebrolysin + donepezil , Ever Neuro Pharma GmbH ,20-Oct-04, Phase 2 , Unknown status\,,,, Celiac Disease , Larazotide acetate (AT1001) , Alba Therapeutics ,20-Apr-09, Phase 2 , Completed\,,,, Parkinson's Disease , Entacapone , Novartis ,20-Feb-03, Phase 2 , Completed\,,,, Chronic Kidney Disease , GCS-100 , La Jolla Pharmaceutical Company , June 2013 , Phase 2 , Completed\,,,, Alzheimer's Disease , 3APS , Bellus Health Inc ,20-Sep-05, Phase 2 , Completed\,,,, Peripheral Artery Disease , Ticagrelor , AstraZeneca ,20-Dec-12, Phase 3 , Unknown status\,,,, Crohn Disease , Infliximab 10 mg/kg , Centocor, Inc. , Phase 3 , Completed\,,,, Alzheimer's Disease , LY450139 , Eli Lilly and Company ,20-Mar-08, May 1996 , Phase 3 , Completed\,,, Chronic Graft-versus-host Disease , Rituximab , Northside Hospital, Inc. , Phase 3 , Completed\,,,, Inflammatory Bowel Disease , MT-1303 , Mitsubishi Tanabe Pharma Corporation , June 2012 , April 2011 , Phase 2 , Completed\,,, Kashin-Beck Disease , Biological Antioxidant Supplementation , Innovative Humanitarian Solutions , July 2007 , Phase 1 , Completed\,,,, Alzheimer's Disease , Razadyne ER , Duke University ,20-Oct-06, Phase 2 , Unknown status\,,,, Alzheimer's Disease , galantamine , Johnson & Johnson Pharmaceutical Research & Development, L.L.C. , Phase 4 , Terminated\,,,, Coronary Disease , Everolimus-eluting stent (Xience) , Deutsches Herzzentrum Muenchen ,20-Dec-07, March 31,2006, Phase 3 , Completed\,, Alzheimer's Disease , Rivastigmine 5 and 10 cm^2 patch , Novartis ,20-Nov-07, Phase 4 , Completed\,,,, Mitochondrial Diseases , EPI-743 , Edison Pharmaceuticals Inc ,20-Feb-10, Phase 4 , Completed\,,,, Parkinson's Disease , Carbidopa-Levodopa , Oregon Health and Science University ,20-Aug-08, Phase 2 , Active, not recruiting\,,, Parkinson's Disease , Lokomat\'ae , Azienda Ospedaliero Universitaria Maggiore della Carita ,20-Oct-10, Phase 2 , Completed\,,,, Parkinson's Disease , KW-6002 (istradefylline) , Kyowa Kirin Pharmaceutical Development, Inc. , Phase 2 , Unknown status\,,,, Parkinson's Disease , Amantadine , Northwestern University , June 2011 , April 2002 , Phase 2 , Completed\,,, Crohn's Disease ,683699, GlaxoSmithKline ,20-Oct-04, Phase 3 , Terminated\,,,, Spondyloarthritis , Adalimumab , University of Alberta , July 2009 , Phase 2 , Completed\,,,, Alzheimer's Disease , Galantamine (Reminyl\'ae) , Ludwig-Maximilians - University of Munich ,20-Sep-06, Phase 4 , Withdrawn\,,,, Parkinson's Disease , Cogane\'99 (PYM50028) , Phytopharm ,20-Apr-09, Phase 4 , Unknown status\,,,, Parkinson's Disease , Rasagiline , University of Florida ,20-Dec-09, Phase 1 , Completed\,,,, Gastroesophageal Reflux , Esomeprazole , AstraZeneca ,20-Apr-05, Phase 4 , Completed\,,,, Crohn's Disease , Certolizumab Pegol , UCB Celltech ,20-Apr-09, Phase 3 , Completed\,,,, Cardiovascular Disease , exercise aerobic , Federal University of Pelotas ,20-Sep-11, Phase 2 , Terminated\,,,, Sickle Cell Disease , Omega-3 Fatty Acids: Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) , Thomas Jefferson University ,20-Oct-10, Phase 4 , Enrolling by invitation\,,,, Raynaud's Disease , SLx-2101 , Kadmon Corporation, LLC , Phase 2 , Unknown status\,,,, Alzheimer's Disease , Rosiglitazone XR (extended release) oral tablets , GlaxoSmithKline ,20-Dec-04, June 2007 , Phase 2 , Completed\,,, Coronary Artery Disease , E5555 , Eisai Inc. ,20-Sep-07, Phase 2 , Terminated\,,,, Alzheimer's Disease , Cognitive Training , University of Kansas ,20-Feb-08, Phase 2 , Completed\,,,, Thyroid Eye Disease , Prostaglandin Analog , Stanford University ,20-Aug-13, Phase 2 , Completed\,,,, Inflammation , NNC0114-0006 , Novo Nordisk A/S ,20-Feb-13, Phase 4 , Unknown status\,,,, Huntington's Disease , Minocycline , FDA Office of Orphan Products Development ,20-Sep-01, Phase 2 , Completed\,,,, Age Related Macular Degeneration , ziv-aflibercept drug , Rafic Hariri University Hospital , June 2014 , Phase 1 , Completed\,,,, Chronic Kidney Disease. , Paracalcitol ," Fondazione C.N.R./Regione Toscana ""G. Monasterio""", Pisa, Phase 1 , Unknown status\,,,, End Stage Renal Disease , Aliskiren , Novartis , June 2010 , Italy , June 2011 , Phase 3 , Completed\,, Gastroesophageal Reflux Disease , E3810 , Eisai Co., Ltd. , Phase 1 , Completed\,,,, Coronary Artery Disease , Everolimus Eluting Stent or Zotalolimus Eluting Stent , Yonsei University ,20-Aug-10, September 2013 , Phase 3 , Completed\,,, Chronic Obstructive Pulmonary Disease , GS-5745 , Gilead Sciences ,20-Mar-14, Phase 4 , Unknown status\,,,, Idiopathic Parkinson's Disease , Rotigotine , UCB Pharma , July 2012 , Phase 1 , Completed\,,,, Alzheimer's Disease , rosiglitazone , GlaxoSmithKline , June 2006 , Phase 3 , Completed\,,,, Parkinson's Disease , ParkNet , Radboud University ,20-May-06, Phase 2 , Completed\,,,, Celiac Disease , AT-1001 , Alba Therapeutics ,20-Jan-06, Phase 3 , Completed\,,,, Huntington's Disease , Stimulation , Heinrich-Heine University, Duesseldorf , Phase 1 , Completed\,,,, Graves Disease , Potassium Iodide , University of Massachusetts, Worcester , May 2009 , Phase 1 , Completed\,,, Diabetic Kidney Disease , GS-4997 , Gilead Sciences , June 2014 , April 2005 , Phase 4 , Completed\,,, Parkinson's Disease , Donepezil , Oregon Health and Science University ,20-Dec-11, Phase 2 , Completed\,,,, Alzheimer's Disease , ASP0777 , Astellas Pharma Inc , June 2011 , Phase 4 , Unknown status\,,,, Alzheimer's Disease , Rivastigmine Transdermal Patch , Novartis ,20-Feb-03, Phase 1 , Completed\,,,, Cardiovascular Diseases , PolyPill , Tehran University of Medical Sciences ,20-Feb-11, Phase 3 , Completed\,,,, HEMOGLOBIN SC DISEASE , Mg Pidolate , Baylor College of Medicine ,20-Jan-01, Phase 3 , Active, not recruiting\,,, Autosomal Dominant Polycystic Kidney Disease , Tolvaptan (OPC-41061) , Otsuka Pharmaceutical Development & Commercialization, Inc. , Phase 2 , Terminated\,,,, Crohn's Disease , adalimumab , Abbott ,20-Dec-06, September 2014 , Phase 3 , Enrolling by invitation\,,, HIV Infections , Vinblastine sulfate , National Institute of Allergy and Infectious Diseases (NIAID) ,2-Nov, Phase 3 , Completed\,,,, Alzheimer's Disease , florbetapir 18F , Avid Radiopharmaceuticals ,20-Sep-09,1999, Phase 2 , Completed\,,, Allergic Conditions , Lactobacillus reuteri , Linkoeping University ,20-Feb-01, Phase 2 , Completed\,,,, Pulmonary Disease, Chronic Obstructive , Comparison of two different modes for weaning from mechanical ventilation , Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital , Phase 2 , Completed\,,,, Alzheimer's Disease , Ketasyn\'99 (AC-1202) , Accera, Inc. , April 2007 , Phase 4 , Completed\,,, Alzheimer's Disease , Drug: EVP-6124 , FORUM Pharmaceuticals Inc ,20-Oct-13, October 2004 , Phase 2 , Completed\,,, Alzheimer's Disease , Drug: EVP-6124 , FORUM Pharmaceuticals Inc ,20-Oct-13, Phase 3 , Terminated\,,,, Stem Cell Transplantation , Cyclophosphamide Dose Level 1 , Children's Hospital Los Angeles ,20-Feb-07, Phase 3 , Terminated\,,,, Dent's Disease , Hydrochlorothiazide , Assistance Publique - H\'f4pitaux de Paris , July 2003 , Phase 2 , Terminated\,,,, Autoimmune Inner Ear Disease , gevokizumab , XOMA (US) LLC ,20-Aug-13, Phase 2 , Terminated\,,,, Alzheimer Disease , ACC-001 + QS-21 , Pfizer ,20-May-07, Phase 2 , Completed\,,,, Alzheimer's Disease , risperidone , Janssen Pharmaceutical K.K. ,20-Mar-02, Phase 2 , Completed\,,,, Pelvic Inflammatory Disease , Moxifloxacin (Avelox, BAY12-8039) , Bayer , Phase 3 , Terminated\,,,, Peripheral Arterial Disease , Allopurinol , University of Dundee ,20-Feb-11, January 2007 , Phase 3 , Completed\,,, Crohn's Disease , probiotics , The Baruch Padeh Medical Center, Poriya , Phase 4 , Completed\,,,, Alzheimer's Disease , doxycycline , Hamilton Health Sciences Corporation ,20-Feb-07, December 2012 , Phase 4 , Unknown status\,,, Parkinson's Disease , IRX4204 , Io Therapeutics ,20-Aug-14, Phase 3 , Unknown status\,,,, Patients With Parkinson's Disease. , Virtual exercises , Faculdade Evangelica do Parana ,20-Feb-13, Phase 1 , Completed\,,,, Idiopathic Parkinson's Disease , Placebo , UCB Pharma ,20-Feb-11, Phase 4 , Completed\,,,, Parkinson's Disease , BF2.649 (Pitolisant) , Bioprojet ,20-Mar-10, Phase 4 , Completed\,,,, Pulmonary Disease, Chronic Obstructive , CNTO 6785 , Janssen Research & Development, Phase 3 , Completed\,,,, Disease Progression , Restasis , Innovative Medical ,20-Dec-07, LLC , November 2013 , Phase 2 , Completed\,, Alzheimer's Disease , Memantine , Florida Atlantic University , July 2007 , Phase 4 , Completed\,,,, Proliferative Thyroid Disease , Diindolylmethane (DIM) , The New York Eye & Ear Infirmary ,20-Nov-06, Phase 4 , Completed\,,,, Crohn's Disease , 4-Aminosalicylic acid , Jacobus Pharmaceutical ,20-Jan-07, Phase 0 , Terminated\,,,, Parkinson's Disease , Resonator Device , pico-tesla Magnetic Therapies, LLC , Phase 2 , Terminated\,,,, Sickle Cell Disease , 6R-BH4 (sapropterin dihydrochloride) , BioMarin Pharmaceutical ,20-Apr-07, March 2009 , Phase 3 , Unknown status\,,, Liver Disease , Cholate testing , Northwestern University , June 2015 , Phase 2 , Completed\,,,, Coronary Heart Disease , gemfibrozil , VA Office of Research and Development , June 1991 , Phase 0 , Enrolling by invitation\,,,, Meniere's Disease , SPI-1005 , Sound Pharmaceuticals, Incorporated , Phase 3 , Completed\,,,, Diabetes , Self-Care Stimulating Disease Prevention Program , National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,20-Nov-08, December 2015 , Phase 1 , Enrolling by invitation\,,, Beh\'e7et's Disease , Intravitreal Infliximab , Cairo University ,20-Jan-13, Phase 3 , Completed\,,,, Alzheimer's Disease , LY2886721 , Eli Lilly and Company ,20-Mar-12, Phase 1 , Completed\,,,, Alzheimer Disease , Galantamine HBr , Xian-Janssen Pharmaceutical Ltd. ,20-Mar-04, Phase 1 , Terminated\,,,, Coronary Heart Disease , Atorvastatin , Yonsei University , June 2009 , Phase 3 , Completed\,,,, Coronary Heart Disease (CHD) , anacetrapib , Merck Sharp & Dohme Corp. ,20-Mar-08, Phase 4 , Unknown status\,,,, Alzheimer Disease , Huperzine A , National Institute on Aging (NIA) ,20-Apr-04, Phase 3 , Active, not recruiting\,,, Parkinson's Disease , methylphenidate , Oregon Health and Science University , July 2004 , Phase 2 , Completed\,,,, Alzheimer's Disease , TPI-287 2 mg/m2 , University of California, San Francisco , Phase 2 , Completed\,,,, Chronic Obstructive Pulmonary Disease (COPD) , NVA237 , Novartis Pharmaceuticals ,20-Mar-12, November 2013 , Phase 1 , Active, not recruiting\,, Alzheimer's Disease , Computer-based Cognitive Training , Posit Science Corporation ,20-Sep-04, Phase 3 , Completed\,,,, Heart Diseases , PiCCO Catheter (Pulsiocath 5F) , University of Zurich , July 2009 , Phase 1 , Completed\,,,, Gaucher Disease , Taliglucerase alfa , Protalix ,20-Aug-10, Phase 4 , Completed\,,,, Chronic Obstructive Pulmonary Disease (COPD) , Indacaterol 150 ,,, Phase 4 , Completed\,,,,\f1 \uc0\u956 ,,,,,,,,,\f0 g , Novartis , November 2007 , Phase 3 ,,,,,, Crohn's Disease , Rifabutin, Clarithromycin, and Clofazimine , Completed\,,,,, Crohn's Disease , GSK1605786A , GlaxoSmithKline ,20-Nov-11, Medstar Health Research Institute , January 2007 , Phase 4 , Unknown status\,, Alzheimer's Disease , G-CSF; filgrastim , University of South Florida , June 2009 , Phase 3 , Terminated\,,,, Parkinson's Disease , Exercise Programme , Oxford Brookes University ,20-Sep-11, Phase 1 , Completed\,,,, Parkinson's Disease , KW-6500 , Kyowa Hakko Kirin Company, Limited , Phase 2 , Completed\,,,, Parkinson's Disease , Eltoprazine HCl , Amarantus BioScience Holdings, Inc. , July 2009 , Phase 3 , Completed\,,, Sickle Cell Disease , Simvastatin , Children's Hospital & Research Center Oakland , June 2007 , May 2015 , Phase 2 , Active, not recruiting\,, Alzheimer Disease , Deep Brain Stimulation (Fornix DBS) , University Health Network, Toronto , Phase 1 , Completed\,,,, Parkinson Disease, Idiopathic , SPM 962 , UCB Pharma , March 2007 , Phase 1 , Unknown status\,,, Parkinson's Disease , Istradefylline , Kyowa Hakko Kirin Company, Limited , March 2004 , Phase 3 , Completed\,,, Huntington Disease , Memantine , University of British Columbia ,20-Sep-11, October 2009 , Phase 3 , Completed\,,, Crohn's Disease , GS-5745 , Gilead Sciences ,20-Apr-15, Phase 2 , Completed\,,,, Kawasaki Disease , IVIG (1g/kg,once) , Children's Hospital of Fudan University , Phase 2 , Active, not recruiting\,,, Parkinson's Disease , LUBIPROSTONE , Baylor College of Medicine ,20-Feb-09, January 2014 , Phase 3 , Completed\,,, Dyskinesias , talampanel , Teva Pharmaceutical Industries ,20-Dec-06, Phase 4 , Completed\,,,, Avascular Necrosis of Femur Head , Stem Cell Graft Group , Federal University of Bahia ,20-Aug-06, Phase 1 , Completed\,,,, Parkinson's Disease , minocycline , University of Rochester ,20-May-03, Phase 1 , Enrolling by invitation\,,,, Alzheimer Disease , NIC5-15 , VA Office of Research and Development ,20-Jan-07, Phase 2 , Completed\,,,, Alzheimer's Disease , donepezil HCl (Aricept) , Eisai Inc. , July 2007 , Phase 2 , Completed\,,,, Mild Cognitive Impairment , Minocycline , Huntington Medical Research Institutes ,20-Sep-11, Phase 4 , Completed\,,,, Parkinson Disease , Levodopa (drug), intraduodenal administration , University Hospital, Phase 2 , Completed\,,,, Alzheimer Disease , DMXB-A , CoMentis ,20-Nov-06, Akershus , January 2006 , Phase 4 , Completed\,, End-Stage Renal Disease , Telavancin , University of Michigan , July 2015 , Phase 2 , Completed\,,,, Alzheimer's Disease , MK0249 , Merck Sharp & Dohme Corp. ,20-Nov-06, Phase 4 , Completed\,,,, Alzheimer's Disease , masitinib (AB1010) , AB Science ,20-Feb-06, Phase 2 , Completed\,,,, Coronary Disease , Caffeine , Sheba Medical Center ,20-Nov-07, Phase 2 , Completed\,,,, Alzheimer's Disease , donepezil , Vanderbilt University ,20-Dec-06, Phase 3 , Completed\,,,, Parkinson's Disease , SLV308 , Solvay Pharmaceuticals ,20-Oct-05, Phase 1 , Unknown status\,,,, Chronic Kidney Disease , GCS-100 , La Jolla Pharmaceutical Company ,20-Jan-13, Phase 3 , Completed\,,,, Alzheimer's Disease , Etanercept , Life Extension Foundation Inc. ,20-Feb-10, Phase 1 , Completed\,,,, Graft Versus Host Disease , Rituximab , University Health Network, Toronto , Phase 1 , Completed\,,,, Paget's Disease of Bone , Zoledronic acid , Novartis Pharmaceuticals ,20-Oct-08, May 2010 , Phase 2 , Terminated\,,, Parkinson's Disease , CERE-120: AAV2-NTN , Ceregene , June 2005 , Phase 4 , Completed\,,,, Crohn's Disease , Certolizumab Pegol (CDP870) , UCB Pharma ,20-Dec-03, Phase 1 , Completed\,,,, Parkinson Disease , Pramipexole , Boehringer Ingelheim ,19-Apr-99, Phase 3 , Completed\,,,, Parkinson's Disease , AVE8112 , Michael J. Fox Foundation for Parkinson's Research ,20-Jan-13, Phase 3 , Completed\,,,, Chagas Disease , Benznidazole , Hospital Universitari Vall d'Hebron Research Institute ,20-Sep-10, Phase 1 , Terminated\,,,, Parkinson's Disease , Lokomat , VA Office of Research and Development ,20-Oct-08, Phase 2 , Completed\,,,, Dementia , risperidone , Johnson & Johnson Pharmaceutical Research & Development, L.L.C. , Phase 1 , Completed\,,,, Chronic Kidney Disease , PRT-201 , Proteon Therapeutics ,20-Sep-09, December 2000 , Phase 3 , Completed\,,, Chronic Obstructive Pulmonary Disease (COPD) , Budesonide/formoterol (Symbicort\'ae Turbuhaler\'ae) , AstraZeneca , July 2011 , Phase 1 , Completed\,,,, Alzheimer Disease , Donepezil (Aricept) , Pfizer ,20-Oct-02, Phase 4 , Completed\,,,, Lymphoproliferative Disorder , therapeutic allogeneic lymphocytes , University of Edinburgh ,20-Mar-01, Phase 3 , Completed\,,,, Gaucher Disease , OGT 918 , National Institute of Neurological Disorders and Stroke (NINDS) , July 2002 , Phase 3 , Unknown status\,,,, Chronic Kidney Disease , paricalcitol , Abbott ,20-Nov-09, Phase 2 , Completed\,,,, Alzheimer's Disease , Nerve Growth Factor , NsGene A/S ,20-Jan-08, Phase 3 , Completed\,,,, Mild to Severe Alzheimer's Disease , Donepezil HCl , Eisai Inc. ,20-Jan-08, Phase 1 , Unknown status\,,,, Graft vs Host Disease , ASEDs , National Eye Institute (NEI) ,20-Nov-13, Phase 4 , Completed\,,,, Lymphoproliferative Disorders , MEDI-507 , MedImmune LLC ,20-Apr-04, Phase 2 , Terminated\,,,, Idiopathic Parkinson's Disease , CVT-301 , Acorda Therapeutics ,20-Apr-13, Phase 1 , Terminated\,,,, Alzheimer's Disease , ACC-001 3 ,,, Phase 2 , Completed\,,,,\f1 \uc0\u956 ,,,,,,,,,\f0 g/ QS-21 50 ,,,,,,,,,\f1 \uc0\u956 ,,,,,,,,,\f0 g , Pfizer , February 2011 , Phase 2 ,,,,,, Alzheimer Disease , Leuprolide acetate , Voyager Pharmaceutical Corporation ,20-Mar-03, Completed\,,,,, Sickle Cell Disease , L-citrulline tablets, 1000 mg , Angiogenix , Phase 2 , Completed\,,,, Coat's Disease , anecortave acetate , Manhattan Eye, Ear & Throat Hospital , June 21,2006, Phase 1 , Unknown status\,,},,,, March 2002 , Phase 2 , Completed\,,,